Constitutively	O
activated	O
Akt-1	B-protein
is	O
vital	O
for	O
the	O
survival	O
of	O
human	B-cell_type
monocyte-differentiated	I-cell_type
macrophages	I-cell_type
.	O

Role	O
of	O
Mcl-1	B-protein
,	O
independent	O
of	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappaB	I-protein
,	O
Bad	B-protein
,	O
or	O
caspase	O
activation	O
.	O

Recent	O
data	O
from	O
mice	O
deficient	O
for	O
phosphatase	B-protein
and	O
tensin	B-DNA
homologue	I-DNA
deleted	O
from	O
chromosome	B-DNA
10	I-DNA
or	O
src	B-protein
homology	I-protein
2	I-protein
domain-containing	I-protein
5	I-protein
'	I-protein
inositol	I-protein
phosphatase	I-protein
,	O
phosphatases	B-protein
that	O
negatively	O
regulate	O
the	O
phosphatidylinositol	B-protein
3-kinase	I-protein
(	O
PI3K	B-protein
)	O
pathway	O
,	O
revealed	O
an	O
increased	O
number	O
of	O
macrophages	B-cell_type
in	O
these	O
animals	O
,	O
suggesting	O
an	O
essential	O
role	O
for	O
the	O
PI3K	B-protein
pathway	O
for	O
macro-phage	B-cell_type
survival	O
.	O

Here	O
,	O
we	O
focused	O
on	O
the	O
role	O
of	O
the	O
PI3K-regulated	B-protein
serine/threonine	I-protein
kinase	I-protein
Akt-1	B-protein
in	O
modulating	O
macrophage	B-cell_type
survival	O
.	O

Akt-1	B-protein
was	O
constitutively	O
activated	O
in	O
human	B-cell_type
macrophages	I-cell_type
and	O
addition	O
of	O
the	O
PI3K	B-protein
inhibitor	O
,	O
LY294002	O
,	O
suppressed	O
the	O
activation	O
of	O
Akt-1	B-protein
and	O
induced	O
cell	O
death	O
.	O

Furthermore	O
,	O
suppression	O
of	O
Akt-1	B-protein
by	O
inhibition	O
of	O
PI3K	B-protein
or	O
a	O
dominant	B-protein
negative	I-protein
(	I-protein
DN	I-protein
)	I-protein
Akt-1	I-protein
resulted	O
in	O
loss	O
of	O
mitochondrial	O
transmembrane	O
potential	O
,	O
activation	O
of	O
caspases-9	B-protein
and	I-protein
-3	I-protein
,	O
and	O
DNA	O
fragmentation	O
.	O

The	O
effects	O
of	O
PI3K	B-protein
inhibition	O
were	O
reversed	O
by	O
the	O
ectopic	O
expression	O
of	O
constitutively	O
activated	O
Akt-1	B-protein
or	O
Bcl-x	B-protein
(	I-protein
L	I-protein
)	I-protein
.	O

Inhibition	O
of	O
PI3K	B-protein
/Akt-1	O
pathway	O
either	O
by	O
LY294002	O
or	O
DN	B-protein
Akt-1	I-protein
had	O
no	O
effect	O
on	O
the	O
constitutive	O
or	O
inducible	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappaB	I-protein
in	O
human	B-cell_type
macrophages	I-cell_type
.	O

However	O
,	O
after	O
inhibition	O
of	O
the	O
PI3K	B-protein
/	O
Akt-1	B-protein
pathway	O
,	O
a	O
marked	O
decrease	O
in	O
the	O
expression	O
of	O
the	O
antiapoptotic	B-protein
molecule	I-protein
Mcl-1	B-protein
,	O
but	O
not	O
other	O
Bcl-2	B-protein
family	I-protein
members	I-protein
was	O
observed	O
,	O
and	O
Mcl-1	B-protein
rescued	O
macrophages	B-cell_type
from	O
LY294002-induced	O
cell	O
death	O
.	O

Further	O
,	O
inhibition	O
of	O
Mcl-1	B-protein
by	O
antisense	O
oligonucleotides	O
,	O
also	O
resulted	O
in	O
macrophage	B-cell_type
apoptosis	O
.	O

Thus	O
,	O
our	O
findings	O
demonstrate	O
that	O
the	O
constitutive	O
activation	O
of	O
Akt-1	B-protein
regulates	O
macrophage	B-cell_type
survival	O
through	O
Mcl-1	B-protein
,	O
which	O
is	O
independent	O
of	O
caspases	B-protein
,	O
NF-kappaB	B-protein
,	O
or	O
Bad	B-protein
.	O

Introduction	NULL
Constitutively	NULL
Activated	NULL
Akt-1	NULL
Is	NULL
Vital	NULL
for	NULL
the	NULL
Survival	NULL
of	NULL
Human	NULL
Monocyte-differentiated	NULL
Macrophages	NULL
:	NULL
Role	NULL
of	NULL
Mcl-1	NULL
,	NULL
Independent	NULL
of	NULL
Nuclear	NULL
Factor	NULL
(	NULL
NF	NULL
)	NULL
-KB	NULL
,	NULL
Bad	NULL
,	NULL
or	NULL
Caspase	NULL
Activation	NULL
Hongtao	NULL
Liu	NULL
,	NULL
Harris	NULL
Perlman	NULL
,	NULL
Lisa	NULL
J.	NULL
Pagliari	NULL
,	NULL
and	NULL
Richard	NULL
M.	NULL
Pope	NULL
Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Northwestern	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
and	NULL
the	NULL
VA	NULL
Chicago	NULL
Health	NULL
Care	NULL
System	NULL
,	NULL
Lakeside	NULL
Division	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60611	NULL
Abstract	NULL
Recent	NULL
data	NULL
from	NULL
mice	NULL
deficient	NULL
for	NULL
phosphatase	NULL
and	NULL
tensin	NULL
homologue	NULL
deleted	NULL
from	NULL
chromosome	NULL
10	NULL
or	NULL
src	NULL
homology	NULL
2	NULL
domain-containing	NULL
5	NULL
inositol	NULL
phosphatase	NULL
,	NULL
phosphatases	NULL
that	NULL
negatively	NULL
regulate	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI3K	NULL
)	NULL
pathway	NULL
,	NULL
revealed	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
macrophages	NULL
in	NULL
these	NULL
animals	NULL
,	NULL
suggesting	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
the	NULL
PI3K	NULL
pathway	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
role	NULL
of	NULL
the	NULL
PI3K-regulated	NULL
serine/threonine	NULL
kinase	NULL
Akt-1	NULL
in	NULL
modulating	NULL
macrophage	NULL
survival	NULL
.	NULL

Akt-1	NULL
was	NULL
constitutively	NULL
activated	NULL
in	NULL
human	NULL
macrophages	NULL
and	NULL
addition	NULL
of	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
,	NULL
LY294002	NULL
,	NULL
suppressed	NULL
the	NULL
activation	NULL
of	NULL
Akt-1	NULL
and	NULL
induced	NULL
cell	NULL
death	NULL
.	NULL

Furthermore	NULL
,	NULL
suppression	NULL
of	NULL
Akt-1	NULL
by	NULL
inhibition	NULL
of	NULL
PI3K	NULL
or	NULL
a	NULL
dominant	NULL
negative	NULL
(	NULL
DN	NULL
)	NULL
Akt-1	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
mitochondrial	NULL
transmembrane	NULL
potential	NULL
,	NULL
activation	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
,	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
PI3K	NULL
inhibition	NULL
were	NULL
reversed	NULL
by	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
constitutively	NULL
activated	NULL
Akt-1	NULL
or	NULL
Bcl-x	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
pathway	NULL
either	NULL
by	NULL
LY294002	NULL
or	NULL
DN	NULL
Akt-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
constitutive	NULL
or	NULL
inducible	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-KB	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
antiapoptotic	NULL
molecule	NULL
Mcl-1	NULL
,	NULL
but	NULL
not	NULL
other	NULL
Bcl-2	NULL
family	NULL
members	NULL
was	NULL
observed	NULL
,	NULL
and	NULL
Mcl-1	NULL
rescued	NULL
macrophages	NULL
from	NULL
LY	NULL
294002-induced	NULL
cell	NULL
death	NULL
.	NULL

Further	NULL
,	NULL
inhibition	NULL
of	NULL
Mcl-1	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
,	NULL
also	NULL
resulted	NULL
in	NULL
macrophage	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
findings	NULL
demonstrate	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Akt-1	NULL
regulates	NULL
macrophage	NULL
survival	NULL
through	NULL
Mcl-1	NULL
,	NULL
which	NULL
is	NULL
independent	NULL
of	NULL
caspases	NULL
,	NULL
NF-KB	NULL
,	NULL
or	NULL
Bad	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
-	NULL
cell	NULL
death	NULL
*	NULL
apoptosis	NULL
*	NULL
PI3K	NULL
*	NULL
dominant	NULL
negative	NULL
Akt-1	NULL
Â«	NULL
mitochondrial	NULL
transmembrane	NULL
potential	NULL
Macrophages	NULL
are	NULL
critical	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
diseases	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
1	NULL
)	NULL
,	NULL
atherosclerosis	NULL
and	NULL
Crohn	NULL
's	NULL
disease	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Unlike	NULL
monocytes	NULL
,	NULL
macrophages	NULL
are	NULL
long-lived	NULL
cells	NULL
,	NULL
resistant	NULL
to	NULL
many	NULL
apoptotic	NULL
stimuli	NULL
including	NULL
Fas	NULL
and	NULL
TNF-a	NULL
death	NULL
receptor	NULL
ligation	NULL
,	NULL
ionizing	NULL
radiation	NULL
,	NULL
and	NULL
multiple	NULL
antineoplastic	NULL
or	NULL
cytotoxic	NULL
agents	NULL
(	NULL
3	NULL
)	NULL
.	NULL

We	NULL
recently	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
Fas-associated	NULL
death	NULL
domain-like	NULL
IL-1B-converting	NULL
enzyme-inhibitory	NULL
protein	NULL
protected	NULL
differentiated	NULL
macrophages	NULL
from	NULL
Fas-mediated	NULL
apoptosis	NULL
(	NULL
3	NULL
)	NULL
and	NULL
that	NULL
constitutively	NULL
activated	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
*-KB	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
expression	NULL
Address	NULL
correspondence	NULL
to	NULL
Richard	NULL
M.	NULL
Pope	NULL
,	NULL
Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Northwestern	NULL
University	NULL
Medical	NULL
School	NULL
and	NULL
the	NULL
VA	NULL
Chicago	NULL
Health	NULL
Care	NULL
System	NULL
,	NULL
Lakeside	NULL
Division	NULL
,	NULL
303	NULL
E.	NULL
Chicago	NULL
Ave.	NULL
,	NULL
Ward	NULL
3-315	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60611	NULL
.	NULL

Phone	NULL
:	NULL
312-503-8003	NULL
;	NULL
Fax	NULL
:	NULL
312-503-0994	NULL
;	NULL
E-mail	NULL
:	NULL
rmp158	NULL
@	NULL
nwu.edu	NULL
of	NULL
A1/Bfl-1	NULL
,	NULL
mitochondrial	NULL
homeostasis	NULL
and	NULL
macrophage	NULL
survival	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
mechanisms	NULL
that	NULL
may	NULL
uniquely	NULL
contribute	NULL
to	NULL
macrophage	NULL
survival	NULL
have	NULL
not	NULL
been	NULL
fully	NULL
elucidated	NULL
.	NULL

Apoptosis	NULL
may	NULL
be	NULL
initiated	NULL
by	NULL
ligation	NULL
of	NULL
specific	NULL
death	NULL
receptors	NULL
,	NULL
such	NULL
as	NULL
Fas	NULL
or	NULL
TNFRA1	NULL
.	NULL

Death	NULL
receptor	NULL
signaling	NULL
activates	NULL
caspase-8	NULL
(	NULL
5	NULL
)	NULL
,	NULL
which	NULL
is	NULL
capable	NULL
of	NULL
cleaving	NULL
caspase-3	NULL
.	NULL

In	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
caspase-8	NULL
activation	NULL
may	NULL
directly	NULL
induce	NULL
loss	NULL
of	NULL
mitochondrial	NULL
transmembrane	NULL
po	NULL
*Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
ANY	NULL
.	NULL

,	NULL
,	NULL
mitochondrial	NULL
transmembrane	NULL
po-tential	NULL
;	NULL
Ad	NULL
,	NULL
adenovirus	NULL
;	NULL
AIF	NULL
,	NULL
apoptosis-inducing	NULL
factor	NULL
;	NULL
DN	NULL
,	NULL
dominant	NULL
negative	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GFP	NULL
,	NULL
green	NULL
fluorescence	NULL
protein	NULL
;	NULL
INV	NULL
,	NULL
inverted	NULL
antisense	NULL
oligonucleotides	NULL
;	NULL
moi	NULL
,	NULL
multiplicity	NULL
of	NULL
infection	NULL
;	NULL
MTT	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
bromide	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
NIK	NULL
,	NULL
NF-kB-inducing	NULL
kinase	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
PI3K	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
;	NULL
PTEN	NULL
,	NULL
phosphatase	NULL
and	NULL
tensin	NULL
homologue	NULL
deleted	NULL
from	NULL
chromosome	NULL
10	NULL
.	NULL

113	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

Â©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
Â«	NULL
0022-1007/2001/07/113/13	NULL
$	NULL
5.00	NULL
Volume	NULL
194	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
July	NULL
16	NULL
,	NULL
2001	NULL
113-125	NULL
http	NULL
:	NULL
//www.jem.org/cgi/content/full/194/2/113	NULL
tential	NULL
(	NULL
AYF	NULL
,	NULL
,	NULL
)	NULL
through	NULL
activation	NULL
of	NULL
Bid	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
apoptosis	NULL
may	NULL
be	NULL
initiated	NULL
at	NULL
the	NULL
mitochondria	NULL
by	NULL
disruption	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
,	NULL
,	NULL
and	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
into	NULL
the	NULL
cytosol	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Mitochondria	NULL
integrity	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
Bcl-2	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
includes	NULL
both	NULL
antiapoptotic	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Bcl-2	NULL
,	NULL
Bcl-x	NULL
,	NULL
and	NULL
A1/Bfl-1	NULL
;	NULL
reference	NULL
8	NULL
)	NULL
and	NULL
proapoptotic	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Bax	NULL
,	NULL
Bik	NULL
,	NULL
Bak	NULL
,	NULL
Bad	NULL
,	NULL
and	NULL
Bid	NULL
;	NULL
reference	NULL
7	NULL
)	NULL
family	NULL
members	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
either	NULL
src	NULL
homology	NULL
2	NULL
domain-containing	NULL
5	NULL
'	NULL
inositol	NULL
phosphatase	NULL
or	NULL
phosphatase	NULL
and	NULL
tensin	NULL
homologue	NULL
deleted	NULL
from	NULL
chromosome	NULL
10	NULL
(	NULL
PTEN	NULL
)	NULL
possess	NULL
increased	NULL
numbers	NULL
of	NULL
macrophages	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
phosphatases	NULL
normally	NULL
function	NULL
to	NULL
suppress	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI3K	NULL
)	NULL
pathway	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
pathway	NULL
is	NULL
critical	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

The	NULL
serine/threonine	NULL
kinase	NULL
Akt-1	NULL
is	NULL
a	NULL
major	NULL
target	NULL
of	NULL
PI3K	NULL
(	NULL
13	NULL
)	NULL
,	NULL
which	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
including	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
growth	NULL
and	NULL
survival	NULL
fac-tors	NULL
,	NULL
and	NULL
integrin	NULL
ligation	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
PI3K/	NULL
Akt-1	NULL
pathway	NULL
protects	NULL
against	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
apoptotic	NULL
stimuli	NULL
.	NULL

Although	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
protection	NULL
have	NULL
not	NULL
been	NULL
fully	NULL
elucidated	NULL
,	NULL
the	NULL
phosphorylation	NULL
Bad	NULL
or	NULL
caspase-9	NULL
,	NULL
suppression	NULL
of	NULL
FasL	NULL
expression	NULL
,	NULL
and	NULL
NF-KB	NULL
activation	NULL
may	NULL
be	NULL
induced	NULL
through	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
(	NULL
16-22	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
prior	NULL
study	NULL
demonstrated	NULL
that	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K	NULL
pathway	NULL
resulted	NULL
in	NULL
apoptosis	NULL
of	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
15	NULL
)	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
promotes	NULL
macrophage	NULL
survival	NULL
is	NULL
not	NULL
known	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
Akt-1	NULL
in	NULL
the	NULL
survival	NULL
of	NULL
primary	NULL
human	NULL
monocyte-differentiated	NULL
macrophages	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
Akt-1	NULL
was	NULL
constitutively	NULL
expressed	NULL
and	NULL
activated	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

Inhibition	NULL
of	NULL
Akt-1	NULL
activation	NULL
resulted	NULL
in	NULL
macrophage	NULL
apoptosis	NULL
mediated	NULL
through	NULL
the	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
.	NULL

Activated	NULL
Akt-1	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
Akt-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
Fas	NULL
or	NULL
FasL	NULL
,	NULL
nor	NULL
the	NULL
expression	NULL
or	NULL
phosphorylation	NULL
of	NULL
Bad	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
was	NULL
associated	NULL
with	NULL
decreased	NULL
Mcl-1	NULL
expression	NULL
,	NULL
while	NULL
other	NULL
anti-	NULL
or	NULL
proapoptotic	NULL
Bel-2	NULL
proteins	NULL
were	NULL
not	NULL
altered	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
constitutively	NULL
activated	NULL
PI3K	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
Akt-1	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
Mcl-1	NULL
,	NULL
which	NULL
were	NULL
essential	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
.	NULL

-	NULL
Trypan	NULL
blue	NULL
,	NULL
LY294002	NULL
,	NULL
and	NULL
polymyxin	NULL
B	NULL
sulfate	NULL
were	NULL
from	NULL
Sigma-Aldrich	NULL
.	NULL

Lipofectamine	NULL
was	NULL
from	NULL
GIBCO	NULL
BRL	NULL
.	NULL

Propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
was	NULL
from	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
and	NULL
rhodamine	NULL
123	NULL
(	NULL
Rh123	NULL
)	NULL
was	NULL
from	NULL
Molecular	NULL
Probes	NULL
.	NULL

The	NULL
caspase	NULL
inhibitors	NULL
and	NULL
substrate	NULL
,	NULL
zVAD	NULL
fmk	NULL
,	NULL
zLEHD	NULL
fmk	NULL
,	NULL
and	NULL
Ac-LEVD-AFC	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Enzyme	NULL
System	NULL
Products	NULL
.	NULL

Cell	NULL
Isolation	NULL
and	NULL
Culture	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
countercurrent	NULL
elutriation	NULL
from	NULL
commercially	NULL
obtained	NULL
buffy	NULL
coats	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
differentiated	NULL
in	NULL
vitro	NULL
for	NULL
7	NULL
d	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
20	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
and	NULL
1	NULL
pg/ml	NULL
polymyxin	NULL
B	NULL
sulfate	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
cultured	NULL
in	NULL
DMEM	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
.	NULL

Adenovirus	NULL
Infection	NULL
of	NULL
Human	NULL
Macrophages	NULL
.	NULL

-	NULL
Differentiated	NULL
macrophages	NULL
were	NULL
infected	NULL
for	NULL
2	NULL
h	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
at	NULL
the	NULL
indicated	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
moi	NULL
)	NULL
with	NULL
replication-defective	NULL
adenoviruses	NULL
(	NULL
Ads	NULL
)	NULL
expressing	NULL
either	NULL
B-galactosidase	NULL
(	NULL
Ad-Bgal	NULL
)	NULL
,	NULL
green	NULL
fluorescence	NULL
protein	NULL
(	NULL
AdGFP	NULL
)	NULL
,	NULL
dominant	NULL
negative	NULL
(	NULL
DN	NULL
)	NULL
Akt-1	NULL
(	NULL
AdDNAkt-1	NULL
)	NULL
,	NULL
activated	NULL
Akt-1	NULL
(	NULL
AdMyrAkt-1	NULL
)	NULL
,	NULL
or	NULL
Bel-x	NULL
;	NULL
,	NULL
(	NULL
AdBcl-x	NULL
;	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
from	NULL
macrophages	NULL
incubated	NULL
in	NULL
control	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
50	NULL
jum	NULL
LY	NULL
294002	NULL
or	NULL
infected	NULL
with	NULL
either	NULL
AdGFP	NULL
or	NULL
AdDNAkt-1	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
.	NULL

An	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
KB	NULL
binding	NULL
sites	NULL
of	NULL
HIV	NULL
/Ig	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
detect	NULL
NF-KB	NULL
binding	NULL
,	NULL
was	NULL
employed	NULL
for	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Promoter	NULL
Activity	NULL
Assay	NULL
.	NULL

-	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
using	NULL
lipofectamine	NULL
with	NULL
1	NULL
jug	NULL
of	NULL
the	NULL
3xKB	NULL
promoter-reporter	NULL
plasmid	NULL
(	NULL
4	NULL
)	NULL
plus	NULL
1	NULL
jug	NULL
of	NULL
a	NULL
plasmid-expressing	NULL
constitutively	NULL
active	NULL
Akt-1	NULL
or	NULL
a	NULL
control	NULL
plasmid	NULL
,	NULL
with	NULL
or	NULL
without	NULL
1	NULL
ug	NULL
of	NULL
a	NULL
plasmid-expressing	NULL
NF-KB	NULL
p65	NULL
.	NULL

Promoter	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLUs	NULL
)	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
(	NULL
RLU	NULL
per	NULL
jug	NULL
protein	NULL
)	NULL
.	NULL

Viability	NULL
Assays	NULL
.	NULL

-	NULL
PI	NULL
exclusion	NULL
and	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-y1	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
(	NULL
MTT	NULL
)	NULL
cleavage	NULL
were	NULL
employed	NULL
to	NULL
assess	NULL
macrophage	NULL
viability	NULL
.	NULL

PI	NULL
was	NULL
added	NULL
just	NULL
before	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
the	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
cell	NULL
death	NULL
(	NULL
PI*	NULL
cells	NULL
)	NULL
in	NULL
each	NULL
culture	NULL
.	NULL

MTT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
supplier	NULL
and	NULL
values	NULL
were	NULL
calculated	NULL
relative	NULL
to	NULL
control	NULL
cultures	NULL
.	NULL

Additionally	NULL
,	NULL
transient	NULL
cotransfections	NULL
were	NULL
employed	NULL
to	NULL
determine	NULL
if	NULL
expression	NULL
of	NULL
Mcl-1	NULL
could	NULL
rescue	NULL
RAW	NULL
264.7	NULL
cells	NULL
from	NULL
death	NULL
induced	NULL
by	NULL
LY294002	NULL
treatment	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.5	NULL
jug	NULL
of	NULL
CMV-EGFP	NULL
expression	NULL
plasmid	NULL
plus	NULL
2.5	NULL
jug	NULL
of	NULL
plasmids	NULL
pCI-neo	NULL
or	NULL
pCI-Mcl-1	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
wM	NULL
LY294002	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h.	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
GFP-expressing	NULL
cells	NULL
were	NULL
quantified	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Mdd-1	NULL
Antisense	NULL
.	NULL

-	NULL
Mcl-1	NULL
phosphorothioate	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
Mcl-1	NULL
(	NULL
AS	NULL
)	NULL
and	NULL
control	NULL
inverted	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
INV	NULL
)	NULL
were	NULL
synthesized	NULL
by	NULL
Intergrated	NULL
DNA	NULL
Technology	NULL
,	NULL
Inc	NULL
.	NULL

The	NULL
sequences	NULL
employed	NULL
were	NULL
described	NULL
previously	NULL
as	NULL
Mcl-AS-8	NULL
and	NULL
MclinvAS-8	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Primary	NULL
macrophages	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
Mcl-1	NULL
AS	NULL
or	NULL
INV	NULL
(	NULL
100	NULL
M	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
,	NULL
and	NULL
examined	NULL
for	NULL
Mcl-1	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
apoptosis	NULL
by	NULL
determination	NULL
of	NULL
subdiploid	NULL
DNA	NULL
content	NULL
.	NULL

Determination	NULL
of	NULL
Subdiploid	NULL
DNA	NULL
Content	NULL
.	NULL

-	NULL
At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
cultures	NULL
were	NULL
stained	NULL
with	NULL
PI	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
subdiploid	NULL
DNA	NULL
peak	NULL
(	NULL
<	NULL
2N	NULL
DNA	NULL
)	NULL
,	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
GO/G1	NULL
peak	NULL
(	NULL
2N	NULL
DNA	NULL
)	NULL
,	NULL
represents	NULL
apoptotic	NULL
cells	NULL
and	NULL
was	NULL
quantified	NULL
by	NULL
histogram	NULL
analyses	NULL
.	NULL

Determination	NULL
of	NULL
Mitochondrial	NULL
Permeability	NULL
Transition	NULL
.	NULL

-	NULL
Mitochor-drial	NULL
dysfunction	NULL
was	NULL
assessed	NULL
using	NULL
the	NULL
cationic	NULL
lipophilic	NULL
green	NULL
fluorochrome	NULL
rhodamine	NULL
123	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Mean	NULL
fluorescence	NULL
was	NULL
recorded	NULL
for	NULL
each	NULL
sample	NULL
,	NULL
and	NULL
control	NULL
cultures	NULL
at	NULL
each	NULL
time	NULL
point	NULL
were	NULL
designated	NULL
as	NULL
100	NULL
%	NULL
fluorescence	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

-	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
using	NULL
the	NULL
indicated	NULL
antibodies	NULL
:	NULL
rabbit	NULL
anti-phospho-Akt-1	NULL
or	NULL
total	NULL
Akt-1	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
;	NULL
rabbit	NULL
anti-caspase-9	NULL
(	NULL
Calbiochem	NULL
)	NULL
;	NULL
rabbit	NULL
anti-PKC8	NULL
;	NULL
rabbit	NULL
anti-Mcl-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
;	NULL
mouse	NULL
anti-caspase-3	NULL
;	NULL
mouse	NULL
anti-Bcl-2	NULL
;	NULL
rabbit	NULL
anti-Bel-x	NULL
;	NULL
;	NULL
mouse	NULL
anti-Bax	NULL
(	NULL
Transduc-	NULL
114	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
tion	NULL
Laboratories	NULL
)	NULL
;	NULL
rabbit	NULL
anti-Bad	NULL
;	NULL
and	NULL
phospho-Bad	NULL
(	NULL
Cell	NULL
Signaling	NULL
Technology	NULL
)	NULL
,	NULL
or	NULL
mouse	NULL
anti-tubulin	NULL
(	NULL
Calbiochem	NULL
)	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
Bad	NULL
and	NULL
phospho-Bad	NULL
,	NULL
600	NULL
jug	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
jug	NULL
rabbit	NULL
anti-Bad	NULL
and	NULL
50	NULL
pl	NULL
of	NULL
protein	NULL
A	NULL
Sepharose	NULL
beads	NULL
(	NULL
Boehringer	NULL
)	NULL
overnight	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
immunoprecipitated	NULL
complexes	NULL
were	NULL
electrophoresed	NULL
on	NULL
two	NULL
separate	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
membranes	NULL
which	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blotting	NULL
using	NULL
rabbit	NULL
anti-Bad	NULL
and	NULL
phospho-Bad	NULL
,	NULL
respectively	NULL
.	NULL

To	NULL
examine	NULL
cytochrome	NULL
c	NULL
,	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
incubated	NULL
for	NULL
3	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
by	NULL
us	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
homogenized	NULL
for	NULL
1	NULL
min	NULL
and	NULL
centrifuged	NULL
for	NULL
15	NULL
min	NULL
(	NULL
750	NULL
%	NULL
g	NULL
)	NULL
,	NULL
and	NULL
supernatants	NULL
containing	NULL
the	NULL
cytosolic	NULL
fraction	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
cytochrome	NULL
c	NULL
using	NULL
a	NULL
monoclonal	NULL
anti-cyto-chrome	NULL
c	NULL
antibody	NULL
(	NULL
BD	NULL
PharMingen	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Caspase-9	NULL
Activity	NULL
.	NULL

-	NULL
Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
wM	NULL
LY294002	NULL
and/or	NULL
100	NULL
M	NULL
zVAD	NULL
.fmk	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
for	NULL
48	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
and	NULL
suspended	NULL
in	NULL
50	NULL
jul	NULL
of	NULL
lysis	NULL
buffer	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
buffer	NULL
and	NULL
the	NULL
caspase-9	NULL
substrate	NULL
Ac-LEVD-AFC	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
1	NULL
h.	NULL
Fluorescence	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
fluorometer	NULL
at	NULL
400-nm	NULL
excitation	NULL
and	NULL
505-nm	NULL
emission	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Reverse	NULL
Transcription	NULL
PCR	NULL
.	NULL

-	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
was	NULL
used	NULL
for	NULL
reverse	NULL
transcription	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
amplified	NULL
using	NULL
specific	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogeanse	NULL
or	NULL
Mcl-1	NULL
,	NULL
A1	NULL
,	NULL
and	NULL
Bel-x	NULL
;	NULL
,	NULL
primer	NULL
pairs	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
used	NULL
the	NULL
following	NULL
sequences	NULL
for	NULL
the	NULL
Mcl-1	NULL
:	NULL
5-CGGCAGTCGCTGGAGATTAT-3	NULL
``	NULL
'	NULL
(	NULL
526-545	NULL
,	NULL
sense	NULL
)	NULL
and	NULL
5	NULL
!	NULL

-GTGGTGGTGGTTGGTTA-3	NULL
'	NULL
(	NULL
1,062-1,081	NULL
,	NULL
antisense	NULL
;	NULL
reference	NULL
27	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
for	NULL
Al	NULL
were	NULL
:	NULL
5	NULL
!	NULL

-CAGCACATT-GCCTCAACAGC-3	NULL
'	NULL
and	NULL
AGC-3	NULL
'	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
for	NULL
Bcl-x	NULL
;	NULL
were	NULL
:	NULL
5-CCAG-AAAGGATACAGCTGG-3	NULL
'	NULL
and	NULL
5-CTCCTGGATCCAAG-GCTCTA-3	NULL
'	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
GAPDH	NULL
were	NULL
purchased	NULL
from	NULL
CLONTECH	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
Statistical	NULL
Analysis	NULL
.	NULL

-	NULL
Results	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
.	NULL

Significance	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
unpaired	NULL
two-tailed	NULL
Student	NULL
's	NULL
t	NULL
test	NULL
.	NULL

Results	NULL
Akt-1	NULL
Is	NULL
Constitutively	NULL
Activated	NULL
by	NULL
PI3K	NULL
in	NULL
Human	NULL
Monocyte-differentiated	NULL
Macrophages	NULL
.	NULL

Earlier	NULL
studies	NULL
demonstrated	NULL
that	NULL
PI3K	NULL
activation	NULL
and	NULL
pp70Â®Â®Â®	NULL
were	NULL
important	NULL
in	NULL
survival	NULL
of	NULL
peritoneal	NULL
thioglycollate	NULL
elicited	NULL
macrophages	NULL
(	NULL
15	NULL
)	NULL
,	NULL
although	NULL
the	NULL
role	NULL
of	NULL
Akt-1	NULL
was	NULL
not	NULL
examined	NULL
.	NULL

Therefore	NULL
,	NULL
unstimulated	NULL
in	NULL
vitro-differentiated	NULL
human	NULL
macrophages	NULL
were	NULL
examined	NULL
to	NULL
determine	NULL
if	NULL
Akt-1	NULL
was	NULL
constitutively	NULL
activated	NULL
.	NULL

Total	NULL
and	NULL
active	NULL
phospho-Akt-1	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Akt-1	NULL
was	NULL
constitutively	NULL
activated	NULL
in	NULL
monocyte-differentiated	NULL
macrophages	NULL
and	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
LY294002	NULL
suppressed	NULL
activation	NULL
,	NULL
but	NULL
not	NULL
the	NULL
expression	NULL
of	NULL
Akt-1	NULL
at	NULL
24	NULL
and	NULL
36	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Akt-1	NULL
was	NULL
constitutively	NULL
activated	NULL
in	NULL
normal	NULL
macrophages	NULL
and	NULL
its	NULL
activation	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
PI3K	NULL
pathway	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K	NULL
or	NULL
Akt-1	NULL
in	NULL
Macrophages	NULL
Induces	NULL
Cell	NULL
Death	NULL
and	NULL
Apoptosis	NULL
of	NULL
Human	NULL
Monocyte-differentiated	NULL
Macrophages	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
mechanism	NULL
of	NULL
Akt-1	NULL
activation	NULL
,	NULL
monocyte-differentiated	NULL
macrophages	NULL
were	NULL
treated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
,	NULL
LY294002	NULL
(	NULL
from	NULL
12	NULL
jum	NULL
to	NULL
100	NULL
pum	NULL
)	NULL
,	NULL
or	NULL
control	NULL
medium	NULL
115	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

24hrs	NULL
36hrs	NULL
No	NULL
DMSO	NULL
LY	NULL
DMSO	NULL
LY	NULL
rat	NULL
P4	NULL
Â®	NULL
Figure	NULL
1	NULL
.	NULL

Akt-1	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
human	NULL
macrophages	NULL
,	NULL
which	NULL
is	NULL
PI3K	NULL
dependent	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
total	NULL
and	NULL
activated	NULL
Akt-1	NULL
was	NULL
determined	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Activated	NULL
Akt-1	NULL
was	NULL
detected	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
phospho-Akt-1	NULL
(	NULL
P-Akt-1	NULL
,	NULL
the	NULL
activated	NULL
form	NULL
of	NULL
Akt-1	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
from	NULL
macrophages	NULL
treated	NULL
with	NULL
LY294002	NULL
,	NULL
or	NULL
control	NULL
medium	NULL
(	NULL
DMSO	NULL
)	NULL
,	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
were	NULL
probed	NULL
for	NULL
Akt-1	NULL
and	NULL
P-Akt-1	NULL
by	NULL
rabbit	NULL
anti-total	NULL
Akt-1	NULL
or	NULL
phospho-Akt-1	NULL
antibodies	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
LY294002	NULL
(	NULL
LY	NULL
)	NULL
is	NULL
50	NULL
M.	NULL
The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

-	NULL
<	NULL
Â«	NULL
Â»	NULL
Akt	NULL
containing	NULL
DMSO	NULL
for	NULL
48	NULL
h.	NULL
Cell	NULL
death	NULL
,	NULL
determined	NULL
by	NULL
MTT	NULL
,	NULL
was	NULL
observed	NULL
at	NULL
each	NULL
concentration	NULL
of	NULL
LY	NULL
2942002	NULL
employed	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

At	NULL
50	NULL
M	NULL
,	NULL
cell	NULL
death	NULL
was	NULL
detected	NULL
at	NULL
24	NULL
h	NULL
,	NULL
with	NULL
>	NULL
80	NULL
%	NULL
death	NULL
by	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
cell	NULL
death	NULL
was	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
,	NULL
macrophages	NULL
were	NULL
infected	NULL
with	NULL
an	NULL
adenoviral	NULL
vector	NULL
expressing	NULL
a	NULL
DN	NULL
version	NULL
of	NULL
Akt-1	NULL
(	NULL
AdDNAkt-1	NULL
)	NULL
or	NULL
the	NULL
control	NULL
vector	NULL
(	NULL
AdGFP	NULL
)	NULL
at	NULL
concentrations	NULL
ranging	NULL
from	NULL
25	NULL
to	NULL
200	NULL
moi	NULL
for	NULL
48	NULL
h	NULL
(	NULL
4	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Macrophage	NULL
cell	NULL
death	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
dose-responsive	NULL
fashion	NULL
when	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
AdDNAkt-1	NULL
compared	NULL
with	NULL
AdGFP	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
cell	NULL
death	NULL
was	NULL
observed	NULL
by	NULL
24	NULL
h	NULL
of	NULL
infection	NULL
,	NULL
increasing	NULL
to	NULL
>	NULL
80	NULL
%	NULL
by	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
PI3K-activated	NULL
Akt-1	NULL
is	NULL
essential	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
macrophage	NULL
death	NULL
resulting	NULL
from	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
was	NULL
examined	NULL
.	NULL

DNA	NULL
fragmentation	NULL
was	NULL
observed	NULL
by	NULL
12	NULL
h	NULL
,	NULL
which	NULL
increased	NULL
over	NULL
the	NULL
next	NULL
24	NULL
to	NULL
48	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
LY294002	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
or	NULL
infection	NULL
with	NULL
AdDNAkt-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Supporting	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
LY294002	NULL
,	NULL
another	NULL
PI3K	NULL
inhibitor	NULL
,	NULL
Wortmannin	NULL
,	NULL
also	NULL
induced	NULL
cell	NULL
death	NULL
and	NULL
DNA	NULL
fragmentation	NULL
in	NULL
human	NULL
monocyte-differentiated	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
LY294002	NULL
and	NULL
Wortmannin	NULL
induced	NULL
cell	NULL
death	NULL
and	NULL
apoptosis	NULL
in	NULL
murine	NULL
macrophage	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
mitochondria	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
DNA	NULL
fragmentation	NULL
was	NULL
also	NULL
determined	NULL
by	NULL
examining	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
,	NULL
,	NULL
by	NULL
Rh123	NULL
retention	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
was	NULL
observed	NULL
as	NULL
early	NULL
as	NULL
12	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
LY294002	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
or	NULL
infection	NULL
with	NULL
the	NULL
AdDNAkt-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
D	NULL
)	NULL
.	NULL

In	NULL
each	NULL
in-stance	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
AF	NULL
,	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
,	NULL
determined	NULL
by	NULL
DNA	NULL
fragmentation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
and	NULL
DNA	NULL
fragmentation	NULL
were	NULL
detected	NULL
by	NULL
12	NULL
h	NULL
after	NULL
infection	NULL
with	NULL
AdDNAkt-1	NULL
,	NULL
where	NULL
as	NULL
significant	NULL
differences	NULL
were	NULL
first	NULL
observed	NULL
at	NULL
24	NULL
h	NULL
after	NULL
treatment	NULL
with	NULL
LY294002	NULL
.	NULL

Constitutively	NULL
Activated	NULL
Akt-1	NULL
or	NULL
Bcl-x	NULL
;	NULL
Protects	NULL
Macrophages	NULL
from	NULL
LY294002-induced	NULL
DNA	NULL
Fragmentation	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
y	NULL
Â»	NULL
Jo	NULL
gi	NULL
Â»	NULL
_	NULL
$	NULL
10	NULL
3	NULL
|	NULL
Â°	NULL
|	NULL
3	NULL
g	NULL
100	NULL
&	NULL
$	NULL
100	NULL
2	NULL
5	NULL
so	NULL
2	NULL
E-	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
PI3K	NULL
or	NULL
Akt-1	NULL
activation	NULL
re-3	NULL
E	NULL
3	NULL
b	NULL
90	NULL
;	NULL
:	NULL
:	NULL
P	NULL
Z	NULL
sy	NULL
tA	NULL
3	NULL
sults	NULL
in	NULL
macrophage	NULL
cell	NULL
death	NULL
in	NULL
a	NULL
time	NULL
and	NULL
dose	NULL
--	NULL
o	NULL
E	NULL
o	NULL
80	NULL
dependent	NULL
fashion	NULL
.	NULL

Macrophages	NULL
were	NULL
incubated	NULL
with	NULL
g	NULL
Â§	NULL
40	NULL
P	NULL
g	NULL
70	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
LY294002	NULL
at	NULL
concentrations	NULL
rang-	NULL
&	NULL
3	NULL
20	NULL
&	NULL
3	NULL
89	NULL
ing	NULL
from	NULL
12	NULL
to	NULL
100	NULL
M	NULL
(	NULL
A	NULL
)	NULL
or	NULL
at	NULL
50	NULL
uM	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Control	NULL
&	NULL
o	NULL
&	NULL
so	NULL
medium	NULL
possessed	NULL
DMSO	NULL
alone	NULL
.	NULL

Adenoviral	NULL
infection	NULL
0	NULL
12	NULL
25	NULL
50	NULL
100	NULL
ie	NULL
50	NULL
_	NULL
100	NULL
200	NULL
of	NULL
macrophages	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
vector	NULL
express-LY294002	NULL
(	NULL
uM	NULL
)	NULL
AdDNAkt-1	NULL
(	NULL
moi	NULL
)	NULL
ing	NULL
a	NULL
DN	NULL
form	NULL
of	NULL
Akt-1	NULL
(	NULL
AdDNAkt-1	NULL
)	NULL
or	NULL
a	NULL
control	NULL
C	NULL
D	NULL
vector	NULL
(	NULL
AdGFP	NULL
;	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
dosage	NULL
of	NULL
Ad	NULL
used	NULL
is	NULL
a	NULL
presented	NULL
on	NULL
the	NULL
abscissa	NULL
in	NULL
B	NULL
and	NULL
was	NULL
200	NULL
moi	NULL
in	NULL
D.	NULL
25	NULL
Iii/	NULL
[	NULL
2592002	NULL
25	NULL
sxï¬lï¬ikm	NULL
The	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
time	NULL
points	NULL
indicated	NULL
(	NULL
C	NULL
Viable	NULL
cell	NULL
number	NULL
(	NULL
X10000	NULL
)	NULL
Viable	NULL
cell	NULL
number	NULL
(	NULL
X10000	NULL
)	NULL
24h	NULL
48h	NULL
72h	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
24h	NULL
48h	NULL
PI3K	NULL
in	NULL
macrophages	NULL
was	NULL
specifically	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
signaling	NULL
,	NULL
a	NULL
constitutively	NULL
activated	NULL
form	NULL
of	NULL
Akt-1	NULL
(	NULL
MyrAkt-1	NULL
)	NULL
was	NULL
employed	NULL
.	NULL

Macrophages	NULL
were	NULL
infected	NULL
with	NULL
replication-defective	NULL
Ad	NULL
expressing	NULL
constitutively	NULL
activated	NULL
Akt-1	NULL
(	NULL
AdMyrAkt-1	NULL
)	NULL
or	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
AdBgal	NULL
)	NULL
for	NULL
48	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
LYÂ¥294002	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h.	NULL
Expression	NULL
of	NULL
MyrAkt-1	NULL
protected	NULL
against	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
,	NULL
,	NULL
DNA	NULL
fragmentation	NULL
and	NULL
cell	NULL
death	NULL
(	NULL
PI	NULL
uptake	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
appeared	NULL
temporally	NULL
to	NULL
coincide	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
DNA	NULL
fragmentation	NULL
after	NULL
PI3K/Akt-1	NULL
inhibition	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
antiapoptotic	NULL
Bcel-2	NULL
family	NULL
member	NULL
was	NULL
also	NULL
protective	NULL
.	NULL

Infection	NULL
of	NULL
macrophages	NULL
with	NULL
an	NULL
adenoviral	NULL
vector	NULL
expressing	NULL
Bcl-x	NULL
,	NULL
important	NULL
in	NULL
maintaining	NULL
J	NULL
Â»	NULL
Jo	NULL
30	NULL
Â§	NULL
A	NULL
pMso	NULL
**	NULL
Â§	NULL
40	NULL
3	NULL
_	NULL
M	NULL
LY294002	NULL
E=	NULL
]	NULL
Â§	NULL
<	NULL
Â§	NULL
2	NULL
5	NULL
Z	NULL
20	NULL
Â§	NULL
73	NULL
``	NULL
2	NULL
2	NULL
Â§	NULL
A	NULL
Ã©	NULL
â	NULL
5	NULL
a	NULL
Z	NULL
20	NULL
f	NULL
V	NULL
E	NULL
af	NULL
m	NULL
<	NULL
10	NULL
A	NULL
V	NULL
,	NULL
4	NULL
<	NULL
4	NULL
~	NULL
10	NULL
Z	NULL
2	NULL
[	NULL
=s	NULL
0	NULL
0	NULL
12h	NULL
24h	NULL
48h	NULL
72h	NULL
12h	NULL
24h	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
&	NULL
G	NULL
a	NULL
pMsO	NULL
120	NULL
O	NULL
AdBgal	NULL
o	NULL
@	NULL
120	NULL
m	NULL
1LY294002	NULL
fa	NULL
3	NULL
7	NULL
100	NULL
g	NULL
8	NULL
100	NULL
FH	NULL
$	NULL
g	NULL
so	NULL
$	NULL
g	NULL
so	NULL
Â®	NULL
D	NULL
-a	NULL
Â§	NULL
Â§	NULL
co	NULL
sg	NULL
60	NULL
Ã©	NULL
g	NULL
S	NULL
E	NULL
g	NULL
0	NULL
40	NULL
=	NULL
3	NULL
40	NULL
Â§	NULL
s	NULL
A	NULL
a	NULL
2	NULL
$	NULL
%	NULL
20	NULL
=	NULL
5Â°	NULL
20	NULL
E	NULL
E	NULL
0	NULL
i	NULL
12h	NULL
--	NULL
24h	NULL
00	NULL
48h	NULL
__	NULL
72h	NULL
12h	NULL
24h	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
116	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
M	NULL
AdDNAkt-1	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
and	NULL
D	NULL
)	NULL
or	NULL
at	NULL
48	NULL
h	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Survival	NULL
was	NULL
determined	NULL
by	NULL
relative	NULL
MTT	NULL
values	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
control-treaded	NULL
cells	NULL
(	NULL
DMSO	NULL
or	NULL
AdGFP	NULL
)	NULL
,	NULL
or	NULL
as	NULL
viable	NULL
cell	NULL
number	NULL
determined	NULL
by	NULL
counting	NULL
Trypan	NULL
blue	NULL
negative	NULL
cells	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
determined	NULL
by	NULL
unpaired	NULL
Student	NULL
's	NULL
f	NULL
test	NULL
compared	NULL
with	NULL
control	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
*	NULL
1	NULL
SE	NULL
)	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
are	NULL
presented	NULL
,	NULL
which	NULL
was	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

72h	NULL
mitochondrial	NULL
integrity	NULL
(	NULL
29	NULL
)	NULL
,	NULL
not	NULL
only	NULL
protected	NULL
against	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
induced	NULL
by	NULL
LY294002	NULL
,	NULL
but	NULL
also	NULL
against	NULL
DNA	NULL
fragmentation	NULL
and	NULL
PI	NULL
uptake	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
in	NULL
macrophages	NULL
activated	NULL
Akt-1	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
protecting	NULL
mitochondrial	NULL
integrity	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
Activation	NULL
Results	NULL
in	NULL
Release	NULL
of	NULL
Cytochrome	NULL
c	NULL
,	NULL
Activation	NULL
of	NULL
the	NULL
Caspase	NULL
Cascade	NULL
,	NULL
and	NULL
Cleavage	NULL
of	NULL
PKCS	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
mechanism	NULL
of	NULL
the	NULL
apoptosis	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
PI3K/Akt-1	NULL
inhibition	NULL
on	NULL
cytochrome	NULL
c	NULL
release	NULL
and	NULL
caspase	NULL
activation	NULL
were	NULL
examined	NULL
.	NULL

7-d	NULL
macrophages	NULL
were	NULL
treated	NULL
with	NULL
LY294002	NULL
or	NULL
infected	NULL
by	NULL
AdDNAkt-1	NULL
for	NULL
24	NULL
h.	NULL
Cytosolic	NULL
cytochrome	NULL
c	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
assay	NULL
after	NULL
LYÂ¥294002	NULL
treatment	NULL
or	NULL
Akt-1	NULL
inhi-	NULL
D	NULL
AdGFP	NULL
M	NULL
AdDNAkt-1	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
PI3K	NULL
(	NULL
LY294002	NULL
)	NULL
or	NULL
DN	NULL
Akt-1	NULL
results	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
AF	NULL
,	NULL
,	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

Macrophages	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
LY294002	NULL
(	NULL
50	NULL
M	NULL
)	NULL
or	NULL
control	NULL
DMSO	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
for	NULL
12-72	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Macrophages	NULL
were	NULL
infected	NULL
with	NULL
AdDNAkt-1	NULL
or	NULL
the	NULL
control	NULL
vector	NULL
(	NULL
AdGFP	NULL
or	NULL
AdfBgal	NULL
;	NULL
B	NULL
and	NULL
D	NULL
)	NULL
at	NULL
200	NULL
moi	NULL
for	NULL
12-72	NULL
h.	NULL
The	NULL
effects	NULL
on	NULL
apoptosis	NULL
were	NULL
determined	NULL
by	NULL
DNA	NULL
fragmentation	NULL
by	NULL
PI	NULL
staining	NULL
(	NULL
<	NULL
2N	NULL
DNA	NULL
;	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
and	NULL
on	NULL
AY	NULL
,	NULL
,	NULL
determined	NULL
by	NULL
Rh123	NULL
retention	NULL
(	NULL
mean	NULL
fluorescence	NULL
,	NULL
percentage	NULL
of	NULL
control	NULL
)	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
,	NULL
**P	NULL
<	NULL
0.01	NULL
determined	NULL
by	NULL
unpaired	NULL
Student	NULL
's	NULL
Â¢	NULL
test	NULL
compared	NULL
with	NULL
control	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
*	NULL
1	NULL
SE	NULL
)	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
are	NULL
presented	NULL
,	NULL
which	NULL
was	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

48h	NULL
7th	NULL
48h	NULL
72h	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
Mean	NULL
Fluorescence	NULL
J	NULL
>	NULL
(	NULL
%	NULL
control	NULL
Rh123	NULL
)	NULL
ss	NULL
Bs	NULL
DMSO	NULL
uninfected	NULL
gal	NULL
MyrAkt	NULL
Bcl-x	NULL
,	NULL
+LÂ¥29400	NULL
DNA	NULL
Fragmentation	NULL
U	NULL
(	NULL
<	NULL
2N	NULL
DNA	NULL
)	NULL
3	NULL
DMSO	NULL
uninfected	NULL
gal	NULL
-	NULL
MyrAkt	NULL
Bel-x	NULL
,	NULL
+LÂ¥29400	NULL
100	NULL
80	NULL
60	NULL
*	NULL
40	NULL
*	NULL
20	NULL
%	NULL
of	NULL
PI	NULL
positive	NULL
cells	NULL
O	NULL
0	NULL
DMSO	NULL
uninfected	NULL
gal	NULL
MyrAkt	NULL
Bcl-x	NULL
,	NULL
+LÂ¥29400	NULL
;	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Overexpression	NULL
of	NULL
activated	NULL
Akt-1	NULL
(	NULL
Myr-Akt-1	NULL
)	NULL
and	NULL
Bcl-x	NULL
;	NULL
protects	NULL
against	NULL
the	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
,	NULL
,	NULL
DNA	NULL
fragmentation	NULL
and	NULL
PI	NULL
uptake	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
PI3K	NULL
.	NULL

Macrophages	NULL
were	NULL
infected	NULL
with	NULL
Ad	NULL
vectors	NULL
expressing	NULL
activated	NULL
Akt-1	NULL
(	NULL
MyrAkt-1	NULL
)	NULL
,	NULL
Bcl-x	NULL
,	NULL
or	NULL
control	NULL
Bgal	NULL
at	NULL
200	NULL
moi	NULL
for	NULL
48	NULL
h	NULL
,	NULL
then	NULL
treated	NULL
with	NULL
LY294002	NULL
(	NULL
50	NULL
wm	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
mitochondrial	NULL
integrity	NULL
by	NULL
Rh123	NULL
retention	NULL
(	NULL
mean	NULL
flourescence	NULL
,	NULL
percentage	NULL
of	NULL
control	NULL
;	NULL
A	NULL
)	NULL
,	NULL
DNA	NULL
fragmentation	NULL
(	NULL
%	NULL
<	NULL
2N	NULL
DNA	NULL
,	NULL
B	NULL
)	NULL
,	NULL
and	NULL
PI	NULL
uptake	NULL
(	NULL
C	NULL
)	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
determined	NULL
by	NULL
unpaired	NULL
Student	NULL
's	NULL
f	NULL
test	NULL
compared	NULL
with	NULL
control	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
*	NULL
1	NULL
SE	NULL
)	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
are	NULL
presented	NULL
,	NULL
which	NULL
was	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

bition	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

No	NULL
cytochrome	NULL
c	NULL
oxidase	NULL
subunit	NULL
IV	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
cytosolic	NULL
fractions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
mechanism	NULL
of	NULL
apoptosis	NULL
induced	NULL
by	NULL
PI3K/Akt-1	NULL
inhibition	NULL
,	NULL
caspase	NULL
activation	NULL
was	NULL
assessed	NULL
.	NULL

7-d	NULL
macrophages	NULL
were	NULL
infected	NULL
with	NULL
AdGFP	NULL
or	NULL
AdDNAkt-1	NULL
at	NULL
200	NULL
moi	NULL
for	NULL
12	NULL
and	NULL
24	NULL
h.	NULL
Immunoblot	NULL
analyses	NULL
revealed	NULL
that	NULL
the	NULL
proforms	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
were	NULL
decreased	NULL
by	NULL
24	NULL
,	NULL
but	NULL
not	NULL
12	NULL
,	NULL
h	NULL
after	NULL
the	NULL
infection	NULL
of	NULL
AdDNAkt-1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

Additionally	NULL
full-length	NULL
PKC	NULL
,	NULL
which	NULL
is	NULL
cleaved	NULL
by	NULL
active	NULL
caspase-3	NULL
,	NULL
was	NULL
reduced	NULL
at	NULL
24	NULL
,	NULL
but	NULL
not	NULL
12	NULL
,	NULL
h	NULL
after	NULL
infection	NULL
with	NULL
AdDNAkt-1	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
117	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

A	NULL
No	NULL
DMSO	NULL
LY	NULL
GFP	NULL
DNAkt-1	NULL
Cytochrome	NULL
c	NULL
lug	NULL
Tubulin	NULL
&	NULL
&	NULL
a	NULL
&	NULL
4	NULL
B	NULL
12hrs	NULL
24hrs	NULL
No	NULL
-	NULL
GFP	NULL
DNAkt-1	NULL
GFP	NULL
DNAkt-1	NULL
Pro-Caspase	NULL
)	NULL
#	NULL
PMD	NULL
hd	NULL
Pro-Caspase	NULL
3	NULL
w	NULL
Â«	NULL
emmm	NULL
xc	NULL
__	NULL
PMM	NULL
a	NULL
Â»	NULL
_	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
Akt-1	NULL
in	NULL
macrophages	NULL
results	NULL
in	NULL
the	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
,	NULL
activation	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
,	NULL
and	NULL
cleavage	NULL
of	NULL
PKC	NULL
.	NULL

(	NULL
A	NULL
)	NULL
.	NULL

Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
M	NULL
LY294002	NULL
or	NULL
infected	NULL
with	NULL
AdDNAkt-1	NULL
or	NULL
the	NULL
control	NULL
AdGFP	NULL
(	NULL
200	NULL
moi	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
Western	NULL
blots	NULL
performed	NULL
on	NULL
the	NULL
cytosolic	NULL
fraction	NULL
for	NULL
cytochrome	NULL
c	NULL
or	NULL
tubulin	NULL
.	NULL

(	NULL
B	NULL
)	NULL
.	NULL

Macrophages	NULL
were	NULL
infected	NULL
with	NULL
adenoviral	NULL
vectors	NULL
expressing	NULL
DN	NULL
Akt-1	NULL
,	NULL
or	NULL
the	NULL
control	NULL
GFP	NULL
,	NULL
at	NULL
200	NULL
moi	NULL
for	NULL
12	NULL
and	NULL
24	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
collected	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
a	NULL
rabbit	NULL
anti-caspase-9	NULL
,	NULL
rabbit	NULL
anti-PKC8	NULL
,	NULL
mouse	NULL
anti-caspase-3	NULL
,	NULL
and	NULL
mouse	NULL
anti-tubulin	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
pro-form	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
and	NULL
full-length	NULL
PKC8	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

and	NULL
cytochrome	NULL
c	NULL
release	NULL
result	NULL
in	NULL
activation	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
,	NULL
cleavage	NULL
of	NULL
PKC8	NULL
,	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

Caspase	NULL
Inhibition	NULL
Reduces	NULL
DNA	NULL
Fragmentation	NULL
Induced	NULL
by	NULL
the	NULL
Inhibition	NULL
of	NULL
Akt-1	NULL
Activation	NULL
,	NULL
but	NULL
Does	NULL
Not	NULL
Protect	NULL
Mitochondrial	NULL
Integrity	NULL
or	NULL
Promote	NULL
Cell	NULL
Survival	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
role	NULL
of	NULL
caspase	NULL
activation	NULL
during	NULL
macrophage	NULL
apoptosis	NULL
induced	NULL
by	NULL
PI3K/Akt-1	NULL
inhibition	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
a	NULL
general	NULL
caspase	NULL
inhibitor	NULL
(	NULL
z-VAD	NULL
fmk	NULL
)	NULL
or	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
caspase-9	NULL
(	NULL
z-LEHD	NULL
.fmk	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LY294002	NULL
.	NULL

Treatment	NULL
with	NULL
100	NULL
M	NULL
of	NULL
z-V	NULL
AD	NULL
fmk	NULL
or	NULL
z-LEHD	NULL
.fmk	NULL
failed	NULL
to	NULL
prevent	NULL
LY294002-induced	NULL
mitochondrial	NULL
dysfunction	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
or	NULL
cell	NULL
death	NULL
(	NULL
Pl-positive	NULL
cells	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
DNA	NULL
fragmentation	NULL
was	NULL
significantly	NULL
decreased	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
z-VAD	NULL
.fmk	NULL
or	NULL
z-LEHD-.fmk	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
caspase	NULL
activation	NULL
was	NULL
further	NULL
characterized	NULL
by	NULL
examining	NULL
the	NULL
effect	NULL
of	NULL
z-VAD.fmk	NULL
,	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
caspases-9	NULL
and	NULL
-3	NULL
.	NULL

Caspase	NULL
9	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
E	NULL
)	NULL
and	NULL
caspase-3	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
PI3K	NULL
were	NULL
both	NULL
suppressed	NULL
by	NULL
treatment	NULL
with	NULL
z-VAD	NULL
fmk	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
the	NULL
cleavage	NULL
of	NULL
caspase-3	NULL
and	NULL
PKCS	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
E	NULL
)	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
pathway	NULL
was	NULL
also	NULL
suppressed	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
resulted	NULL
in	NULL
cell	NULL
death	NULL
,	NULL
independent	NULL
of	NULL
caspase	NULL
activation	NULL
.	NULL

J	NULL
Â»	NULL
Us	NULL
120	NULL
an	NULL
Â§	NULL
s	NULL
a	NULL
.S	NULL
70	NULL
2	NULL
w=	NULL
+t	NULL
5	NULL
100	NULL
8	NULL
A	NULL
,	NULL
60	NULL
9	NULL
Ã©	NULL
a	NULL
4	NULL
C	NULL
&	NULL
~	NULL
80	NULL
9	NULL
z	NULL
5	NULL
T	NULL
Â§2	NULL
10	NULL
3	NULL
g	NULL
60	NULL
a	NULL
Z	NULL
,	NULL
bad	NULL
5	NULL
Lo	NULL
eq	NULL
30	NULL
a	NULL
3	NULL
40	NULL
a	NULL
C	NULL
230	NULL
A	NULL
Ge	NULL
has	NULL
Â§	NULL
Â°	NULL
z	NULL
Z	NULL
-	NULL
10	NULL
a	NULL
&	NULL
A	NULL
0	NULL
0	NULL
DMSO	NULL
DMSO	NULL
+	NULL
=	NULL
=	NULL
-	NULL
=	NULL
LY294002	NULL
LY294002	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
zVAD	NULL
zVAD	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
Caspase	NULL
9	NULL
Caspase	NULL
9	NULL
_	NULL
-	NULL
-	NULL
=	NULL
=	NULL
+	NULL
inhibitor	NULL
inhibitor	NULL
w	NULL
An	NULL
pr	NULL
&	NULL
$	NULL
1000	NULL
y	NULL
80	NULL
'	NULL
3	NULL
2	NULL
E=	NULL
]	NULL
<	NULL
$	NULL
800	NULL
&	NULL
60	NULL
oa	NULL
Â§	NULL
S	NULL
=	NULL
``	NULL
@	NULL
==	NULL
600	NULL
r=	NULL
40	NULL
3	NULL
``	NULL
-lam	NULL
a	NULL
g	NULL
400	NULL
Â©	NULL
20	NULL
a	NULL
3	NULL
ro	NULL
WJ	NULL
at	NULL
200	NULL
U	NULL
~~	NULL
_	NULL
o	NULL
DMSO	NULL
+	NULL
-	NULL
=	NULL
=	NULL
=	NULL
LY294002	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
zVAD	NULL
=	NULL
+	NULL
+	NULL
*	NULL
Caspase	NULL
9	NULL
_	NULL
-	NULL
-	NULL
=	NULL
-	NULL
+	NULL
inhibitor	NULL
E	NULL
Figure	NULL
6	NULL
.	NULL

No	NULL
DMSO	NULL
LY	NULL
LY+zVAD	NULL
Pro-Caspase	NULL
3	NULL
~	NULL
-	NULL
.	NULL

nog	NULL
0a	NULL
40x	NULL
$	NULL
a	NULL
LY	NULL
LY+zVAD	NULL
Caspase	NULL
inhibitors	NULL
do	NULL
not	NULL
prevent	NULL
the	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
or	NULL
macrophage	NULL
PI	NULL
uptake	NULL
after	NULL
PI3K/Akt-1	NULL
inhibition	NULL
.	NULL

Macrophages	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
jwM	NULL
zVAD.fmk	NULL
,	NULL
the	NULL
caspase-9	NULL
inhibitor	NULL
z-LEHD.fmk	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
or	NULL
control	NULL
medium	NULL
for	NULL
1	NULL
h	NULL
,	NULL
then	NULL
50	NULL
wM	NULL
LY294002	NULL
was	NULL
added	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
for	NULL
mi	NULL
tochondrial	NULL
retention	NULL
of	NULL
Rh123	NULL
(	NULL
mean	NULL
fluorescence	NULL
,	NULL
percentage	NULL
of	NULL
control	NULL
;	NULL
A	NULL
)	NULL
,	NULL
DNA	NULL
frag-	NULL
PKCS	NULL
Tubulin	NULL
Â«	NULL
sagas	NULL
Â«	NULL
alize	NULL
Gillie	NULL
Â»	NULL
Â«	NULL
oms	NULL
Our	NULL
previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
cell	NULL
surface	NULL
Fas-FasL	NULL
interactions	NULL
on	NULL
human	NULL
macrophages	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
after	NULL
the	NULL
reduction	NULL
of	NULL
Fas-associated	NULL
death	NULL
domain-like	NULL
IL-1B-converting	NULL
enzyme-inhibitory	NULL
protein	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Activated	NULL
Akt-1	NULL
may	NULL
suppress	NULL
the	NULL
expression	NULL
of	NULL
FasL	NULL
,	NULL
which	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
phosphorylation	NULL
of	NULL
forkhead	NULL
transcription	NULL
factors	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Fas	NULL
and	NULL
FasL	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
macrophages	NULL
,	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
LY294002	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
Fas-FasL	NULL
interactions	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
macrophages	NULL
were	NULL
pretreated	NULL
with	NULL
antagonistic	NULL
anti-FasL	NULL
antibody	NULL
for	NULL
1	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
LY294002	NULL
.	NULL

The	NULL
antagonistic	NULL
anti-FasL	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
,	NULL
DNA	NULL
fragmentation	NULL
,	NULL
or	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
LY294002	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
mentation	NULL
(	NULL
%	NULL
<	NULL
2N	NULL
DNA	NULL
,	NULL
B	NULL
)	NULL
,	NULL
PI	NULL
uptake	NULL
(	NULL
percentage	NULL
of	NULL
Pl-positive	NULL
cells	NULL
,	NULL
C	NULL
)	NULL
,	NULL
caspase-9	NULL
activity	NULL
(	NULL
D	NULL
)	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
proform	NULL
of	NULL
caspase-3	NULL
and	NULL
full-length	NULL
(	NULL
E	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
methods	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
each	NULL
panel	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
or	NULL
three	NULL
experiments	NULL
.	NULL

ally	NULL
,	NULL
TNF-a	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
of	NULL
macrophages	NULL
,	NULL
even	NULL
after	NULL
adenoviral	NULL
infection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
together	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
protection	NULL
of	NULL
mitochondrial	NULL
integrity	NULL
by	NULL
zVAD.fmk	NULL
,	NULL
suggest	NULL
that	NULL
death	NULL
receptor	NULL
signaling	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
initiating	NULL
LY294002-induced	NULL
AW	NULL
,	NULL
,	NULL
loss	NULL
and	NULL
apoptosis	NULL
.	NULL

There	NULL
Is	NULL
No	NULL
Relationship	NULL
between	NULL
Constitutively	NULL
Activated	NULL
NF-KB	NULL
and	NULL
Akt-1	NULL
in	NULL
Normal	NULL
Macrophages	NULL
.	NULL

_	NULL
We	NULL
recently	NULL
demonstrate	NULL
that	NULL
NF-KB	NULL
was	NULL
constitutively	NULL
activated	NULL
,	NULL
and	NULL
protected	NULL
against	NULL
apoptosis	NULL
,	NULL
in	NULL
differentiated	NULL
macrophages	NULL
(	NULL
4	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
Akt-1	NULL
mediates	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
(	NULL
21	NULL
,	NULL
22	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
potential	NULL
connection	NULL
between	NULL
the	NULL
Akt-1	NULL
and	NULL
NF-KB	NULL
activation	NULL
,	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
activation	NULL
decreased	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
normal	NULL
human	NULL
macrophages	NULL
.	NULL

Macrophages	NULL
were	NULL
treated	NULL
118	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
with	NULL
the	NULL
PI3K	NULL
inhibitor	NULL
LY294002	NULL
for	NULL
24	NULL
and	NULL
48	NULL
h	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
for	NULL
analysis	NULL
by	NULL
EMSA	NULL
.	NULL

Neither	NULL
LY294002	NULL
nor	NULL
DN	NULL
Akt-1	NULL
inhibited	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
human	NULL
monocyte-differentiated	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A-C	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
LY294002	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
TNF-a	NULL
in	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

To	NULL
further	NULL
clarify	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
activation	NULL
of	NULL
Akt-1	NULL
and	NULL
NF-KB	NULL
,	NULL
macrophages	NULL
were	NULL
infected	NULL
with	NULL
an	NULL
adenoviral	NULL
vector	NULL
expressing	NULL
NF-kB-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
;	NULL
reference	NULL
33	NULL
)	NULL
.	NULL

The	NULL
ectopic	NULL
expression	NULL
of	NULL
NIK	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
increase	NULL
of	NULL
NF-KB	NULL
activation	NULL
,	NULL
determined	NULL
by	NULL
EMSA	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
protect	NULL
against	NULL
apoptosis	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
LY	NULL
294002	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
Akt-1	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
determined	NULL
by	NULL
the	NULL
nuclear	NULL
translo-cation	NULL
of	NULL
NF-KB	NULL
and	NULL
that	NULL
increased	NULL
NF-KB	NULL
activation	NULL
did	NULL
not	NULL
protect	NULL
against	NULL
the	NULL
apoptosis	NULL
induced	NULL
after	NULL
he	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
activated	NULL
Akt-1	NULL
may	NULL
enhance	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
activated	NULL
Akt-1	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
was	NULL
examined	NULL
.	NULL

In	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
activated	NULL
A	NULL
B	NULL
TNFo	NULL
.	NULL

mo	NULL
8	NULL
>	NULL
8	NULL
+	NULL
+	NULL
B	NULL
>	NULL
+	NULL
#	NULL
AdGFP	NULL
LPS	NULL
â¬00	NULL
800	NULL
Â®	NULL
0	NULL
R	NULL
e	NULL
+	NULL
8	NULL
#	NULL
DMSO	NULL
Kou	NULL
Â®	NULL
0	NULL
woo	NULL
ge	NULL
%	NULL
o	NULL
til	NULL
%	NULL
LY294002	NULL
-	NULL
.	NULL

.	NULL

.	NULL

1	NULL
$	NULL
.	NULL

.	NULL

+4	NULL
p65	NULL
Ab	NULL
.	NULL

S	NULL
p50	NULL
Ab	NULL
.	NULL

somes	NULL
#	NULL
om	NULL
ger	NULL
Â®	NULL
c	NULL
#	NULL
ms	NULL
oÂ®	NULL
c-Jun	NULL
Ab	NULL
.	NULL

Â£00	NULL
>	NULL
0	NULL
&	NULL
0	NULL
ook	NULL
&	NULL
&	NULL
>	NULL
o	NULL
>	NULL
p6S/p350-	NULL
Â»	NULL
a	NULL
P	NULL
l	NULL
psmpsr	NULL
``	NULL
f	NULL
5	NULL
a	NULL
o	NULL
#	NULL
a	NULL
G	NULL
C	NULL
p	NULL
2	NULL
3	NULL
``	NULL
O	NULL
L8	NULL
DMSO	NULL
24h	NULL
48h	NULL
18	NULL
.	NULL

LY294002	NULL
24h	NULL
48h	NULL
Ã©Ã©	NULL
a	NULL
â¬	NULL
:	NULL
e	NULL
w	NULL
3	NULL
m	NULL
er	NULL
'	NULL
w	NULL
.	NULL

-l	NULL
0	NULL
3	NULL
AdDNAkt-1	NULL
Akt-1	NULL
(	NULL
Myr	NULL
Akt-1	NULL
)	NULL
rescued	NULL
RAW	NULL
264.7	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
LY294002	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Myr	NULL
Akt-1	NULL
failed	NULL
to	NULL
enhance	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
which	NULL
we	NULL
previously	NULL
demonstrated	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
,	NULL
determined	NULL
by	NULL
cotransfection	NULL
of	NULL
a	NULL
3xKkB	NULL
promoter-reporter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
enhancement	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
cotransfection	NULL
of	NULL
the	NULL
plasmid-expressing	NULL
Myr	NULL
Akt-1	NULL
together	NULL
with	NULL
one	NULL
expressing	NULL
the	NULL
transcriptionally	NULL
active	NULL
p65	NULL
subunit	NULL
of	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
)	NULL
.	NULL

Further	NULL
supporting	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
in	NULL
macrophages	NULL
,	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
expression	NULL
of	NULL
A1/Bfl-1	NULL
by	NULL
reverse	NULL
transcription	NULL
PCR	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
B	NULL
)	NULL
,	NULL
which	NULL
is	NULL
exquisitely	NULL
sensitive	NULL
to	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
observations	NULL
demonstrate	NULL
that	NULL
in	NULL
macrophages	NULL
,	NULL
the	NULL
protection	NULL
against	NULL
apoptosis	NULL
observed	NULL
with	NULL
activated	NULL
Akt-1	NULL
is	NULL
not	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
Has	NULL
No	NULL
Effect	NULL
on	NULL
the	NULL
Expression	NULL
of	NULL
Apoptosis-related	NULL
Molecules	NULL
Bcl-2	NULL
,	NULL
Bcl-x	NULL
;	NULL
,	NULL
Bax	NULL
or	NULL
Bad	NULL
,	NULL
but	NULL
Results	NULL
in	NULL
Inhibition	NULL
of	NULL
Mc-1	NULL
.	NULL

-	NULL
Since	NULL
members	NULL
of	NULL
the	NULL
Bcl-2	NULL
family	NULL
control	NULL
mitochondrial	NULL
integrity	NULL
,	NULL
the	NULL
effect	NULL
PI3K/	NULL
Akt-1	NULL
pathway	NULL
inhibition	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
Bcl-2	NULL
family	NULL
members	NULL
was	NULL
examined	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
by	NULL
24h	NULL
48h	NULL
24h	NULL
48h	NULL
(	NULL
c	NULL
Figure	NULL
7	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
Akt-1	NULL
does	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
or	NULL
the	NULL
induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Macrophages	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
cultured	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
50	NULL
M	NULL
-	NULL
LY294002	NULL
-	NULL
or	NULL
-	NULL
control	NULL
DMSO	NULL
for	NULL
2	NULL
h.	NULL
Finally	NULL
macrophages	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/	NULL
ml	NULL
TNF-	NULL
@	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
,	NULL
or	NULL
control	NULL
medium	NULL
as	NULL
indicated	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
harvested	NULL
and	NULL
EMSA	NULL
was	NULL
conducted	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
the	NULL
NF-KB	NULL
complex	NULL
was	NULL
determined	NULL
by	NULL
supershift	NULL
analysis	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
NF-	NULL
Sd	NULL
WVIW	NULL
10.9uo0	NULL
;	NULL
god	NULL
rmyaiip-+sod	NULL
jo.guos+59d	NULL
kB	NULL
p65	NULL
and	NULL
p50	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Macrophages	NULL
were	NULL
infected	NULL
with	NULL
AdDNAkt-1	NULL
or	NULL
control	NULL
AdGFP	NULL
and	NULL
cultured	NULL
in	NULL
serum	NULL
containing	NULL
medium	NULL
for	NULL
another	NULL
for	NULL
24	NULL
and	NULL
48	NULL
h.	NULL
(	NULL
C	NULL
)	NULL
Treatment	NULL
with	NULL
LY294002	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
uM	NULL
LY294002	NULL
or	NULL
control	NULL
DMSO	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h	NULL
,	NULL
before	NULL
harvesting	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
3xB	NULL
promoter-reporter	NULL
plasmid	NULL
(	NULL
1	NULL
jg	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
plasmid-expressing	NULL
activated	NULL
Akt-1	NULL
(	NULL
1	NULL
jug	NULL
MyrAkt	NULL
)	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
a	NULL
plasmid-expressing	NULL
NF-KB	NULL
p65	NULL
(	NULL
1	NULL
jug	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
to	NULL
measure	NULL
luciferase	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
determined	NULL
as	NULL
RLU	NULL
per	NULL
microgram	NULL
of	NULL
protein	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
fold	NULL
compared	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
(	NULL
no	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
mean	NULL
*	NULL
1	NULL
SE	NULL
)	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
are	NULL
presented	NULL
,	NULL
which	NULL
was	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

119	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

LY294002	NULL
did	NULL
not	NULL
influence	NULL
the	NULL
expression	NULL
of	NULL
antiapoptotic	NULL
molecules	NULL
Bcl-2	NULL
or	NULL
Bcl-x	NULL
;	NULL
or	NULL
the	NULL
proapoptotic	NULL
molecule	NULL
Bax	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
after	NULL
infection	NULL
with	NULL
AdDNAkt-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
no	NULL
change	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
phosphorylated	NULL
Bad	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
protection	NULL
of	NULL
mitochondrial	NULL
integrity	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
LY294002	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Bcl-x	NULL
,	NULL
and	NULL
A1/Bfl-1	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
were	NULL
not	NULL
reduced	NULL
after	NULL
PI3K/Akt-1	NULL
inhibition	NULL
by	NULL
LY294002	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
PI3K	NULL
by	NULL
treatment	NULL
with	NULL
LY294002	NULL
,	NULL
or	NULL
infection	NULL
with	NULL
AdDNAkt-1	NULL
,	NULL
suppressed	NULL
Mcl-1	NULL
expression	NULL
in	NULL
macrophages	NULL
by	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
before	NULL
the	NULL
activation	NULL
of	NULL
caspase-3	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
Mcl-1	NULL
may	NULL
be	NULL
the	NULL
downstream	NULL
target	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
responsible	NULL
for	NULL
protecting	NULL
macrophage	NULL
mitochondrial	NULL
integrity	NULL
.	NULL

Mcl-1	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Viability	NULL
.	NULL

Since	NULL
reduction	NULL
of	NULL
Mcl-1	NULL
was	NULL
associated	NULL
with	NULL
cell	NULL
death	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
Mcl-1	NULL
protected	NULL
against	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
RAW	NULL
264.7	NULL
murine	NULL
macrophages	NULL
,	NULL
since	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
induced	NULL
apoptosis	NULL
,	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
was	NULL
the	NULL
same	NULL
as	NULL
observed	NULL
in	NULL
primary	NULL
human	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
GFP-expressing	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
with	NULL
A	NULL
24hrs	NULL
48hrs	NULL
No	NULL
_	NULL
DMSO	NULL
LY	NULL
-	NULL
DMSO	NULL
-	NULL
LY	NULL
Bel-2	NULL
Â«	NULL
m	NULL
Â»	NULL
-	NULL
mmm	NULL
-	NULL
am	NULL
-	NULL
cmm	NULL
h	NULL
Bel-x	NULL
;	NULL
Pro-Caspase	NULL
3	NULL
-	NULL
-	NULL
-	NULL
foe	NULL
Bax	NULL
Â«	NULL
os	NULL
db	NULL
Â«	NULL
me	NULL
-n	NULL
Â«	NULL
it	NULL
i	NULL
Tubuhn	NULL
OWA	NULL
Ot	NULL
tL	NULL
aw	NULL
at	NULL
B	NULL
48hrs	NULL
No	NULL
DMSO	NULL
LY	NULL
Bim	NULL
@	NULL
an	NULL
PBu	NULL
&	NULL
&	NULL
#	NULL
B	NULL
Figure	NULL
8	NULL
.	NULL

|	NULL
Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
apoptosis-related	NULL
molecules	NULL
Bcl-2	NULL
,	NULL
Bcl-x	NULL
;	NULL
,	NULL
Bax	NULL
,	NULL
or	NULL
Bad	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Macrophages	NULL
were	NULL
treated	NULL
with	NULL
LY294002	NULL
(	NULL
LY	NULL
)	NULL
at	NULL
50	NULL
M	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
collected	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
were	NULL
conducted	NULL
using	NULL
mouse	NULL
anti-caspase-3	NULL
,	NULL
mouse	NULL
anti-Bcl-2	NULL
,	NULL
rabbit	NULL
anti-Bcl-x	NULL
;	NULL
,	NULL
mouse	NULL
anti-Bax	NULL
,	NULL
or	NULL
mouse	NULL
anti-tubulin	NULL
antibodies	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
wM	NULL
LY294002	NULL
for	NULL
48	NULL
h	NULL
,	NULL
then	NULL
cell	NULL
lysates	NULL
was	NULL
collected	NULL
and	NULL
immunoprecipitated	NULL
using	NULL
rabbit	NULL
anti-Bad	NULL
antibody	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
probing	NULL
the	NULL
immunoprecipitated	NULL
complex	NULL
with	NULL
specific	NULL
rabbit	NULL
anti-Bad	NULL
(	NULL
Bad	NULL
)	NULL
or	NULL
rabbit	NULL
anti-phospho-Bad	NULL
(	NULL
P-Bad	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
result	NULL
shown	NULL
is	NULL
one	NULL
of	NULL
three	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

a	NULL
control	NULL
vector	NULL
or	NULL
one	NULL
expressing	NULL
Mcl-1	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LY294002	NULL
or	NULL
vehicle	NULL
control	NULL
and	NULL
cell	NULL
viability	NULL
was	NULL
determined	NULL
.	NULL

Mcl-1	NULL
protected	NULL
the	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
from	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
C	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Akt-1	NULL
maintains	NULL
the	NULL
expression	NULL
of	NULL
Mcl-1	NULL
,	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
protection	NULL
of	NULL
mitochondrial	NULL
integrity	NULL
in	NULL
macrophages	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
Mcl-1	NULL
was	NULL
essential	NULL
for	NULL
macrophage	NULL
viability	NULL
,	NULL
7-d	NULL
differentiated	NULL
human	NULL
macrophages	NULL
were	NULL
incubated	NULL
with	NULL
Mcl-1	NULL
antisense	NULL
or	NULL
control	NULL
(	NULL
INV	NULL
)	NULL
oligonucleotides	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
Mcl-1	NULL
by	NULL
the	NULL
antisense	NULL
resulted	NULL
in	NULL
macrophage	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
D	NULL
and	NULL
E	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
Mcl-1	NULL
in	NULL
protecting	NULL
macrophages	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
mitochondrial	NULL
integ-	NULL
rity	NULL
.	NULL

Discussion	NULL
Prior	NULL
studies	NULL
using	NULL
mice	NULL
deficient	NULL
in	NULL
src	NULL
homology	NULL
2	NULL
domain-containing	NULL
5	NULL
'	NULL
inositol	NULL
phosphatase	NULL
or	NULL
PTEN	NULL
demonstrated	NULL
an	NULL
expansion	NULL
of	NULL
their	NULL
macrophage	NULL
populations	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
phosphatases	NULL
normally	NULL
function	NULL
to	NULL
suppress	NULL
the	NULL
PI3K	NULL
pathway	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
pathway	NULL
may	NULL
be	NULL
unique	NULL
and	NULL
critical	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

The	NULL
potential	NULL
mechanisms	NULL
by	NULL
which	NULL
this	NULL
pathway	NULL
may	NULL
be	NULL
important	NULL
in	NULL
macrophage	NULL
survival	NULL
have	NULL
not	NULL
been	NULL
character-ized	NULL
.	NULL

This	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
that	NULL
Akt-1	NULL
was	NULL
constitutively	NULL
activated	NULL
in	NULL
human	NULL
monocyte-differentiated	NULL
macrophages	NULL
,	NULL
and	NULL
that	NULL
specific	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
resulted	NULL
in	NULL
apoptotic	NULL
cell	NULL
death	NULL
mediated	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
mitochondrial	NULL
integrity	NULL
.	NULL

To	NULL
date	NULL
most	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
role	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
in	NULL
proliferating	NULL
cells	NULL
rather	NULL
than	NULL
in	NULL
terminally	NULL
differentiated	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
macrophages	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
in	NULL
the	NULL
differentiated	NULL
human	NULL
macrophages	NULL
was	NULL
not	NULL
characterized	NULL
in	NULL
our	NULL
manu-script	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
factors	NULL
present	NULL
in	NULL
serum	NULL
may	NULL
be	NULL
im-portant	NULL
.	NULL

Lysophosphatidic	NULL
acid	NULL
,	NULL
M-CSF	NULL
,	NULL
and	NULL
1a	NULL
,	NULL
25-dihy-droxyvitamin	NULL
D	NULL
;	NULL
,	NULL
which	NULL
may	NULL
be	NULL
present	NULL
in	NULL
normal	NULL
serum	NULL
,	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
PI3K	NULL
pathway	NULL
(	NULL
15	NULL
,	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
possible	NULL
to	NULL
withhold	NULL
serum	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
,	NULL
since	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
most	NULL
monocytes	NULL
die	NULL
by	NULL
Fas-FasL-mediated	NULL
apoptosis	NULL
without	NULL
serum	NULL
(	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
serum	NULL
deprivation	NULL
for	NULL
24	NULL
to	NULL
96	NULL
h	NULL
after	NULL
differentiation	NULL
did	NULL
not	NULL
result	NULL
in	NULL
macrophage	NULL
death	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
a	NULL
factor	NULL
in	NULL
serum	NULL
was	NULL
not	NULL
necessary	NULL
for	NULL
the	NULL
survival	NULL
of	NULL
terminally	NULL
differentiated	NULL
human	NULL
macrophages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
murine	NULL
thioglycollate-elicited	NULL
macrophages	NULL
and	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
,	NULL
which	NULL
proliferate	NULL
in	NULL
culture	NULL
(	NULL
39	NULL
)	NULL
,	NULL
died	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
or	NULL
CSF-1	NULL
(	NULL
15	NULL
,	NULL
40	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
murine	NULL
macrophages	NULL
(	NULL
15	NULL
,	NULL
40	NULL
)	NULL
may	NULL
not	NULL
be	NULL
terminally	NULL
differentiated	NULL
or	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
protection	NULL
against	NULL
cell	NULL
death	NULL
was	NULL
different	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
proliferation	NULL
or	NULL
activation	NULL
that	NULL
occurred	NULL
during	NULL
recruitment	NULL
and	NULL
isolation	NULL
.	NULL

120	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
A	NULL
24hrs	NULL
36hrs	NULL
B	NULL
No	NULL
DMSO	NULL
LY	NULL
DMSO	NULL
LY	NULL
Md	NULL
A	NULL
&	NULL
A	NULL
%	NULL
--	NULL
Meck	NULL
Tomi	NULL
:	NULL
peas	NULL
~	NULL
24hrs	NULL
36hrs	NULL
isk	NULL
,	NULL
No	NULL
GFP	NULL
DN	NULL
GFP	NULL
DN	NULL
GAPDH	NULL
JJL	NULL
at	NULL
._	NULL
@	NULL
Â»	NULL
<	NULL
>	NULL
dr	NULL
dp	NULL
Â«	NULL
--	NULL
ap	NULL
D	NULL
Mel-1	NULL
Tubulin	NULL
C	NULL
Mcl-1	NULL
3000	NULL
7	NULL
Tubulin	NULL
P	NULL
PT	NULL
&	NULL
2500	NULL
4	NULL
&	NULL
3	NULL
2	NULL
2000	NULL
1	NULL
*	NULL
M	NULL
(	NULL
F	NULL
--	NULL
--	NULL
-3	NULL
[	NULL
g	NULL
15004	NULL
a	NULL
25	NULL
*	NULL
Â£2	NULL
Â»	NULL
&	NULL
,	NULL
1000	NULL
1	NULL
&	NULL
{	NULL
Zt	NULL
Ba	NULL
2G	NULL
15	NULL
3	NULL
-	NULL
Z	NULL
500	NULL
Â§	NULL
V	NULL
10	NULL
W	NULL
w	NULL
M	NULL
0	NULL
1	NULL
&	NULL
5	NULL
pCl-neo	NULL
pCl-neo	NULL
_	NULL
pCI-MCL-1	NULL
o	NULL
lâ	NULL
+LÂ¥294002	NULL
J	NULL
12hrs	NULL
24hrs	NULL
36hrs	NULL
Figure	NULL
9	NULL
.	NULL

PI3K/Akt-1-regu-	NULL
No	NULL
DMSO	NULL
LY	NULL
DMSO	NULL
LY	NULL
DMSO	NULL
LY	NULL
no	NULL
AS	NULL
INV	NULL
lated	NULL
Mcl-1	NULL
is	NULL
necessary	NULL
for	NULL
macrophage	NULL
survival	NULL
.	NULL

Inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
downregulates	NULL
the	NULL
expression	NULL
of	NULL
Mcl-1	NULL
at	NULL
the	NULL
protein	NULL
(	NULL
A	NULL
)	NULL
and	NULL
transcriptional	NULL
(	NULL
B	NULL
)	NULL
levels	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
M	NULL
LY294002	NULL
or	NULL
infected	NULL
with	NULL
AdDNAkt-1	NULL
(	NULL
200	NULL
moi	NULL
)	NULL
for	NULL
24	NULL
or	NULL
36	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
collected	NULL
and	NULL
Western	NULL
blots	NULL
were	NULL
performed	NULL
with	NULL
rabbit	NULL
anti-Mcl-1	NULL
and	NULL
mouse	NULL
anti-tubulin	NULL
antibodies	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Macrophages	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
No	NULL
AS	NULL
INV	NULL
JM	NULL
LY294002	NULL
for	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
36	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Â«	NULL
Gp	NULL
same	NULL
Â«	NULL
sigs	NULL
Then	NULL
the	NULL
total	NULL
RNA	NULL
was	NULL
ex	NULL
tracted	NULL
and	NULL
used	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
cDNA	NULL
.	NULL

PCR	NULL
was	NULL
conducted	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
Mcl-1	NULL
,	NULL
A1	NULL
,	NULL
Bcl-x	NULL
,	NULL
and	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
expression	NULL
of	NULL
Mcl-1	NULL
rescues	NULL
RAW	NULL
264.7	NULL
macrophage-like	NULL
cells	NULL
from	NULL
cell	NULL
death	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

RAW	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
plasmid-expressing	NULL
enhanced	NULL
GFP	NULL
(	NULL
0.5	NULL
jug	NULL
)	NULL
plus	NULL
a	NULL
control	NULL
plasmid	NULL
(	NULL
pCl-neo	NULL
)	NULL
or	NULL
one	NULL
expressing	NULL
Mcl-1	NULL
(	NULL
pCI-MCL-1	NULL
)	NULL
,	NULL
each	NULL
at	NULL
2.5	NULL
pug	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
50	NULL
M	NULL
LY294002	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
number	NULL
of	NULL
enhanced	NULL
GFP-positive	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Macrophages	NULL
were	NULL
treated	NULL
with	NULL
Mcl-1	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
AS	NULL
)	NULL
or	NULL
control	NULL
oligonucleotides	NULL
(	NULL
INV	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
Mcl-1	NULL
expression	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
assay	NULL
(	NULL
D	NULL
)	NULL
and	NULL
apoptosis	NULL
determined	NULL
by	NULL
DNA	NULL
fragmentation	NULL
(	NULL
<	NULL
2N	NULL
DNA	NULL
;	NULL
E	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
each	NULL
panel	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
or	NULL
three	NULL
experiments	NULL
.	NULL

Akt-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
promote	NULL
cell	NULL
survival	NULL
,	NULL
and	NULL
protect	NULL
against	NULL
apoptosis	NULL
,	NULL
by	NULL
a	NULL
number	NULL
of	NULL
mechanisms	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
contributes	NULL
to	NULL
the	NULL
survival	NULL
of	NULL
terminally	NULL
differentiated	NULL
macrophages	NULL
have	NULL
not	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Akt-1	NULL
activation	NULL
,	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
may	NULL
promote	NULL
survival	NULL
by	NULL
protecting	NULL
against	NULL
Fas	NULL
signaling	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
PTEN*'~	NULL
mice	NULL
demonstrate	NULL
impaired	NULL
Fas-mediated	NULL
apoptosis	NULL
that	NULL
is	NULL
restored	NULL
by	NULL
PI3K	NULL
inhibitors	NULL
(	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
do	NULL
not	NULL
support	NULL
a	NULL
role	NULL
for	NULL
death	NULL
receptor	NULL
signaling	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

The	NULL
broad-based	NULL
caspase	NULL
inhibitor	NULL
z-VAD	NULL
fmk	NULL
protected	NULL
against	NULL
DNA	NULL
fragmentation	NULL
,	NULL
a	NULL
characteristic	NULL
feature	NULL
of	NULL
the	NULL
apoptotic	NULL
phenotype	NULL
,	NULL
however	NULL
,	NULL
it	NULL
failed	NULL
to	NULL
protect	NULL
against	NULL
the	NULL
loss	NULL
of	NULL
AF	NULL
,	NULL
,	NULL
or	NULL
cell	NULL
death	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
initiator	NULL
caspase-8	NULL
was	NULL
not	NULL
responsible	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
observed	NULL
no	NULL
change	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
Fas	NULL
or	NULL
FasL	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
and	NULL
antagonistic	NULL
anti-FasL	NULL
antibody	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
apoptosis	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
,	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
death	NULL
receptor	NULL
ligation	NULL
and	NULL
caspase-8	NULL
activation	NULL
did	NULL
not	NULL
initiate	NULL
macrophage	NULL
apoptosis	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

121	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

Akt-1	NULL
may	NULL
regulate	NULL
cell	NULL
survival	NULL
at	NULL
a	NULL
postmitochondrial	NULL
level	NULL
,	NULL
after	NULL
the	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
,	NULL
by	NULL
inhibiting	NULL
the	NULL
activation	NULL
or	NULL
activity	NULL
of	NULL
caspase-9	NULL
(	NULL
18	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
cytochrome	NULL
c-induced	NULL
activation	NULL
of	NULL
caspase-9	NULL
was	NULL
inhibited	NULL
by	NULL
either	NULL
z-V	NULL
AD	NULL
fmk	NULL
or	NULL
activated	NULL
Akt-1	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
macrophages	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
with	NULL
either	NULL
LY294002	NULL
or	NULL
the	NULL
DN	NULL
Akt-1	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
AF	NULL
,	NULL
,	NULL
and	NULL
cytochrome	NULL
c	NULL
release	NULL
.	NULL

However	NULL
,	NULL
caspase	NULL
inhibition	NULL
by	NULL
either	NULL
z-VAD	NULL
.fmk	NULL
or	NULL
a	NULL
caspase-I-specific	NULL
inhibitor	NULL
partially	NULL
protected	NULL
against	NULL
DNA	NULL
fragmentation	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
protect	NULL
against	NULL
the	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
or	NULL
cell	NULL
death	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
the	NULL
protection	NULL
provided	NULL
by	NULL
constitutively	NULL
activated	NULL
Akt-1	NULL
,	NULL
that	NULL
was	NULL
essential	NULL
for	NULL
macrophage	NULL
survival	NULL
,	NULL
was	NULL
upstream	NULL
of	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
and	NULL
did	NULL
not	NULL
require	NULL
caspase	NULL
activation	NULL
.	NULL

Inhibition	NULL
of	NULL
caspase	NULL
activation	NULL
altered	NULL
the	NULL
apoptotic	NULL
phenotype	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
DNA	NULL
fragmentation	NULL
and	NULL
PKC8	NULL
cleavage	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
protect	NULL
against	NULL
cell	NULL
death	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
mechanisms	NULL
other	NULL
than	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
may	NULL
have	NULL
contributed	NULL
directly	NULL
to	NULL
cell	NULL
death	NULL
.	NULL

Apoptosis-inducing	NULL
factor	NULL
(	NULL
AIF	NULL
)	NULL
,	NULL
when	NULL
released	NULL
from	NULL
the	NULL
mitochondria	NULL
after	NULL
the	NULL
loss	NULL
of	NULL
AYF	NULL
,	NULL
,	NULL
,	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
inducing	NULL
chroma-tin	NULL
condensation	NULL
and	NULL
DNA	NULL
fragmentation	NULL
,	NULL
independent	NULL
of	NULL
caspase	NULL
activation	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
a	NULL
role	NULL
AIF	NULL
in	NULL
cell	NULL
death	NULL
,	NULL
z-VAD.fmk	NULL
only	NULL
partially	NULL
protected	NULL
against	NULL
DNA	NULL
fragmentation	NULL
,	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
and	NULL
the	NULL
subsequent	NULL
release	NULL
of	NULL
AIF	NULL
may	NULL
both	NULL
have	NULL
directly	NULL
contributed	NULL
to	NULL
macrophage	NULL
death	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

Supporting	NULL
the	NULL
central	NULL
role	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
Bel-	NULL
,	NULL
protected	NULL
not	NULL
only	NULL
against	NULL
DNA	NULL
fragmentation	NULL
,	NULL
but	NULL
also	NULL
prevented	NULL
the	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
and	NULL
cell	NULL
death	NULL
,	NULL
even	NULL
though	NULL
no	NULL
reduction	NULL
of	NULL
endogenous	NULL
Bcl-x	NULL
,	NULL
or	NULL
Bcel-2	NULL
was	NULL
observed	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
activated	NULL
Akt-1	NULL
phosphorylated	NULL
Bad	NULL
(	NULL
17	NULL
,	NULL
45	NULL
)	NULL
,	NULL
which	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
Bad	NULL
with	NULL
Bcl-x	NULL
}	NULL
,	NULL
thereby	NULL
promoting	NULL
survival	NULL
and	NULL
protecting	NULL
against	NULL
apoptosis	NULL
.	NULL

Although	NULL
this	NULL
mechanism	NULL
would	NULL
result	NULL
in	NULL
apoptosis	NULL
and	NULL
cell	NULL
death	NULL
initiated	NULL
by	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
,	NULL
,	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
or	NULL
phosphorylation	NULL
of	NULL
Bad	NULL
in	NULL
macrophages	NULL
after	NULL
inhibition	NULL
of	NULL
PI3K/Akt-1	NULL
activity	NULL
.	NULL

Similar	NULL
to	NULL
this	NULL
observation	NULL
,	NULL
other	NULL
studies	NULL
have	NULL
not	NULL
observed	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
Bad	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
Akt-1	NULL
in	NULL
fibroblasts	NULL
and	NULL
a	NULL
neuronal	NULL
cell	NULL
line	NULL
(	NULL
19	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
although	NULL
Bad	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
a	NULL
cell-type	NULL
and	NULL
stimulus-specific	NULL
fashion	NULL
,	NULL
it	NULL
was	NULL
not	NULL
involved	NULL
in	NULL
macrophage	NULL
apoptosis	NULL
observed	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

We	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
was	NULL
essential	NULL
for	NULL
the	NULL
survival	NULL
of	NULL
macrophages	NULL
by	NULL
maintaining	NULL
mitochondrial	NULL
integrity	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
Akt-1	NULL
contributed	NULL
to	NULL
NF-KB	NULL
activation	NULL
in	NULL
macrophages	NULL
,	NULL
as	NULL
recently	NULL
demonstrated	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
31	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
observations	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
constitutive	NULL
or	NULL
TNF-o-stimulated	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
TNF-a	NULL
failed	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
Akt-1	NULL
in	NULL
monocytes	NULL
(	NULL
48	NULL
)	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
no	NULL
effect	NULL
of	NULL
Akt-1	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
recent	NULL
studies	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
34	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Our	NULL
study	NULL
directly	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
Myr	NULL
Akt-1	NULL
on	NULL
the	NULL
constitutive	NULL
and	NULL
the	NULL
NF-KB	NULL
p65	NULL
induced	NULL
activation	NULL
of	NULL
a	NULL
NF-KB	NULL
promoter-reporter	NULL
construct	NULL
.	NULL

The	NULL
differences	NULL
observed	NULL
between	NULL
the	NULL
studies	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
experimental	NULL
design	NULL
or	NULL
cell-type	NULL
differences	NULL
(	NULL
34	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Cell-type	NULL
differences	NULL
may	NULL
be	NULL
important	NULL
since	NULL
Myr	NULL
Akt-1	NULL
activated	NULL
a	NULL
KB	NULL
promoter	NULL
in	NULL
313	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
,	NULL
even	NULL
though	NULL
Myr	NULL
Akt-1	NULL
protected	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
against	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K	NULL
pathway	NULL
.	NULL

Further	NULL
supporting	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
NF-KB	NULL
,	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
NIK	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
strong	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
,	NULL
failed	NULL
to	NULL
protect	NULL
against	NULL
cell	NULL
death	NULL
induced	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K	NULL
pathway	NULL
.	NULL

Also	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
activated	NULL
form	NULL
of	NULL
Akt-1	NULL
in	NULL
macrophages	NULL
,	NULL
which	NULL
protected	NULL
against	NULL
the	NULL
apoptosis	NULL
observed	NULL
after	NULL
treatment	NULL
with	NULL
LY294002	NULL
,	NULL
failed	NULL
to	NULL
activate	NULL
NF-	NULL
<	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
previously	NULL
we	NULL
observed	NULL
demonstrated	NULL
that	NULL
the	NULL
antiapoptotic	NULL
molecule	NULL
A1	NULL
was	NULL
an	NULL
important	NULL
downstream	NULL
target	NULL
of	NULL
the	NULL
constitutively	NULL
activated	NULL
NF-KB	NULL
in	NULL
macrophages	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
after	NULL
PI3K/Akt-1	NULL
inhibition	NULL
,	NULL
no	NULL
reduction	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
A1/Bfl-1	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
PI3K/Akt-1	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-kB	NULL
,	NULL
since	NULL
A1/Bfl-1	NULL
expression	NULL
in	NULL
macrophages	NULL
was	NULL
exquisitely	NULL
regulated	NULL
by	NULL
constitutively	NULL
activated	NULL
NF-KB	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
the	NULL
protection	NULL
provided	NULL
by	NULL
the	NULL
constitutively	NULL
activated	NULL
PI3K/Akt-1	NULL
pathway	NULL
in	NULL
macrophages	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
NF-KB	NULL
activation	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
the	NULL
independent	NULL
role	NULL
of	NULL
A1	NULL
,	NULL
regulated	NULL
by	NULL
constitutively	NULL
activated	NULL
NF-KB	NULL
and	NULL
Mcl-1	NULL
,	NULL
regulated	NULL
by	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
in	NULL
maintaining	NULL
mitochondrial	NULL
integrity	NULL
,	NULL
protecting	NULL
against	NULL
spontaneous	NULL
apoptosis	NULL
,	NULL
in	NULL
primary	NULL
differentiated	NULL
macrophages	NULL
.	NULL

The	NULL
independence	NULL
of	NULL
the	NULL
pathways	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
apoptosis	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
A1/	NULL
NF-KB	NULL
does	NULL
not	NULL
result	NULL
in	NULL
activation	NULL
of	NULL
caspase-3	NULL
(	NULL
4	NULL
)	NULL
,	NULL
while	NULL
that	NULL
which	NULL
results	NULL
from	NULL
inhibition	NULL
of	NULL
PI3K/Akt-1/Mel-1	NULL
does	NULL
result	NULL
in	NULL
caspase-3	NULL
activation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
multiple	NULL
pathways	NULL
promote	NULL
macrophage	NULL
survival	NULL
,	NULL
even	NULL
without	NULL
specific	NULL
stimulation	NULL
or	NULL
stress	NULL
.	NULL

Since	NULL
the	NULL
loss	NULL
of	NULL
AW	NULL
,	NULL
,	NULL
induced	NULL
by	NULL
PI3K/Akt-1	NULL
inhibition	NULL
was	NULL
protected	NULL
by	NULL
Bcl-x	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Bcl-2	NULL
family	NULL
members	NULL
was	NULL
examined	NULL
.	NULL

Although	NULL
Akt-1	NULL
regulated	NULL
T	NULL
lymphocyte	NULL
survival	NULL
,	NULL
NF-KB	NULL
activation	NULL
and	NULL
Bcl-x	NULL
,	NULL
expression	NULL
(	NULL
49	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
effect	NULL
of	NULL
PI3K/Akt-1	NULL
inhibition	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
Bcl-x	NULL
,	NULL
consistent	NULL
with	NULL
other	NULL
studies	NULL
(	NULL
19	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
be	NULL
due	NULL
to	NULL
cell-type	NULL
and/or	NULL
stimulus-specific	NULL
differences	NULL
.	NULL

Also	NULL
,	NULL
no	NULL
change	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
antiapoptotic	NULL
molecules	NULL
Bel-2	NULL
or	NULL
A1	NULL
or	NULL
the	NULL
proapoptotic	NULL
molecule	NULL
Bax	NULL
was	NULL
observed	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Mcl-1	NULL
mRNA	NULL
and	NULL
protein	NULL
was	NULL
reduced	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
in	NULL
macrophages	NULL
.	NULL

Supporting	NULL
the	NULL
importance	NULL
of	NULL
Mcl-1	NULL
in	NULL
macrophages	NULL
,	NULL
Mcl-1	NULL
expression	NULL
protected	NULL
against	NULL
the	NULL
apoptotic	NULL
cell	NULL
death	NULL
observed	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
macrophage	NULL
cell	NULL
line	NULL
after	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

Supporting	NULL
the	NULL
relevance	NULL
of	NULL
this	NULL
observation	NULL
,	NULL
apoptosis	NULL
induced	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
was	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
AY	NULL
,	NULL
,	NULL
DNA	NULL
fragmentation	NULL
,	NULL
and	NULL
cell	NULL
death	NULL
that	NULL
was	NULL
prevented	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
activated	NULL
Akt-1	NULL
.	NULL

The	NULL
essential	NULL
role	NULL
of	NULL
Mcl-1	NULL
in	NULL
primary	NULL
macrophages	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
reduction	NULL
of	NULL
Mcl-1	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
resulted	NULL
in	NULL
macrophage	NULL
apoptosis	NULL
.	NULL

An	NULL
earlier	NULL
study	NULL
demonstrated	NULL
that	NULL
ml-1	NULL
was	NULL
regulated	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
through	NULL
a	NULL
transcription	NULL
factor	NULL
complex	NULL
containing	NULL
the	NULL
cAMP	NULL
response-element-binding	NULL
protein	NULL
(	NULL
50	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
Mcl-1	NULL
,	NULL
mediated	NULL
by	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
,	NULL
in	NULL
promoting	NULL
macrophage	NULL
viability	NULL
,	NULL
by	NULL
maintaining	NULL
mitochondrial	NULL
integrity	NULL
.	NULL

Mcl-1	NULL
,	NULL
a	NULL
Bcl-2	NULL
family	NULL
member	NULL
,	NULL
is	NULL
critical	NULL
to	NULL
embryonic	NULL
development	NULL
since	NULL
deletion	NULL
of	NULL
this	NULL
gene	NULL
resulted	NULL
in	NULL
periim-plantation	NULL
embryonic	NULL
lethality	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Mcl-1	NULL
has	NULL
been	NULL
found	NULL
to	NULL
exhibit	NULL
differentiation	NULL
stage-specific	NULL
expression	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
hematopoietic	NULL
lineages	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
Mcl-1	NULL
delayed	NULL
apoptosis	NULL
induced	NULL
by	NULL
c-myc	NULL
,	NULL
growth	NULL
factor	NULL
with	NULL
122	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
drawal	NULL
,	NULL
and	NULL
other	NULL
cytotoxic	NULL
agents	NULL
,	NULL
and	NULL
reduced	NULL
the	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
from	NULL
mitochondria	NULL
(	NULL
53-55	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
Mcl-1	NULL
expression	NULL
was	NULL
essential	NULL
in	NULL
maintaining	NULL
mitochondrial	NULL
integrity	NULL
in	NULL
macrophages	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
exogenous	NULL
death-inducing	NULL
signal	NULL
.	NULL

Supporting	NULL
this	NULL
conclusion	NULL
,	NULL
mice	NULL
transgenic	NULL
for	NULL
Mcl-1	NULL
demonstrated	NULL
prolonged	NULL
viability	NULL
of	NULL
both	NULL
mature	NULL
and	NULL
immature	NULL
myeloid	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
antisense-mediated	NULL
inhibition	NULL
of	NULL
Mcl-1	NULL
resulted	NULL
in	NULL
apoptosis	NULL
of	NULL
PMA-treated	NULL
U937	NULL
mono-cytic	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
observations	NULL
support	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
mediated-expression	NULL
of	NULL
Mcl-1	NULL
in	NULL
maintaining	NULL
macrophage	NULL
viability	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Mcl-1	NULL
protects	NULL
macrophage	NULL
mitochondrial	NULL
integrity	NULL
was	NULL
not	NULL
examined	NULL
,	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
analysis	NULL
,	NULL
Mcl-1	NULL
bound	NULL
avidly	NULL
to	NULL
Bax	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Bax	NULL
overexpression	NULL
resulted	NULL
in	NULL
death	NULL
by	NULL
induction	NULL
of	NULL
mitochondrial	NULL
permeability	NULL
transition	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
results	NULL
observed	NULL
after	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
PI3K/Akt-1	NULL
pathway	NULL
.	NULL

Supporting	NULL
this	NULL
mechanism	NULL
,	NULL
reduction	NULL
of	NULL
Bcl-x	NULL
,	NULL
another	NULL
Bcl-2	NULL
family	NULL
member	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
Bax	NULL
,	NULL
resulted	NULL
in	NULL
Bax-mediated	NULL
cell	NULL
death	NULL
(	NULL
60	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
reduction	NULL
of	NULL
Mcl-1	NULL
in	NULL
macrophages	NULL
may	NULL
lead	NULL
to	NULL
enhanced	NULL
Bax	NULL
activity	NULL
,	NULL
although	NULL
the	NULL
expression	NULL
of	NULL
Bax	NULL
was	NULL
not	NULL
altered	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
cell	NULL
death	NULL
mediated	NULL
through	NULL
the	NULL
loss	NULL
of	NULL
mitochondrial	NULL
integrity	NULL
.	NULL

These	NULL
observations	NULL
provide	NULL
insights	NULL
into	NULL
potentially	NULL
novel	NULL
mechanisms	NULL
to	NULL
regulate	NULL
macrophage	NULL
survival	NULL
in	NULL
conditions	NULL
such	NULL
as	NULL
atherosclerosis	NULL
or	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

We	NULL
thank	NULL
Kenneth	NULL
Walsh	NULL
(	NULL
Tufts	NULL
University	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
providing	NULL
AdDNAkt-1	NULL
,	NULL
AdMyrAkt-1	NULL
,	NULL
and	NULL
AdBcl-x	NULL
,	NULL
and	NULL
Dr.	NULL
Stephen	NULL
Nimer	NULL
(	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
for	NULL
providing	NULL
plasmid	NULL
pCI-Mcl-1	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Kathleen	NULL
Carrigan	NULL
for	NULL
assistance	NULL
in	NULL
virus	NULL
preparation	NULL
and	NULL
Mary	NULL
Paniaqua	NULL
for	NULL
the	NULL
flow	NULL
cytometry	NULL
conducted	NULL
at	NULL
the	NULL
Robert	NULL
H.	NULL
Lurie	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
Flow	NULL
Cytometry	NULL
Core	NULL
Facility	NULL
of	NULL
the	NULL
Northwestern	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NO1-AR62221	NULL
and	NULL
P60-AR30692	NULL
)	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
to	NULL
R.M	NULL
.	NULL

Pope	NULL
.	NULL

Submitted	NULL
:	NULL
3	NULL
January	NULL
2001	NULL
Revised	NULL
:	NULL
22	NULL
May	NULL
2001	NULL
Accepted	NULL
:	NULL
29	NULL
May	NULL
2001	NULL
References	NULL
1	NULL
.	NULL

Feldmann	NULL
,	NULL
M.	NULL
,	NULL
FM	NULL
.	NULL

Brennan	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Maini	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
cytokines	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
:	NULL
397-440	NULL
.	NULL

2	NULL
.	NULL

Schwertschlag	NULL
,	NULL
U.S.	NULL
,	NULL
W.L	NULL
.	NULL

Trepicchio	NULL
,	NULL
K.H	NULL
.	NULL

Dykstra	NULL
,	NULL
J.C.	NULL
Keith	NULL
,	NULL
K.J	NULL
.	NULL

Turner	NULL
,	NULL
and	NULL
A.J	NULL
.	NULL

Dorner	NULL
.	NULL

1999	NULL
.	NULL

Hematopoietic	NULL
,	NULL
immunomodulatory	NULL
and	NULL
epithelial	NULL
effects	NULL
of	NULL
interleukin-11	NULL
.	NULL

Leukemia	NULL
.	NULL

13:1307-1315	NULL
.	NULL

3	NULL
.	NULL

Perlman	NULL
,	NULL
H.	NULL
,	NULL
L.J	NULL
.	NULL

Pagliari	NULL
,	NULL
C.	NULL
Georganas	NULL
,	NULL
T.	NULL
Mano	NULL
,	NULL
K.	NULL
Walsh	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Pope	NULL
.	NULL

1999	NULL
.	NULL

FLICE-inhibitory	NULL
protein	NULL
expression	NULL
during	NULL
macrophage	NULL
differentiation	NULL
confers	NULL
resistance	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

190:1679-1688	NULL
.	NULL

4	NULL
.	NULL

Pagliari	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
H.	NULL
Perlman	NULL
,	NULL
H.	NULL
Liu	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Pope	NULL
.	NULL

2000	NULL
.	NULL

Macrophages	NULL
require	NULL
constitutive	NULL
NF-KB	NULL
activation	NULL
to	NULL
maintain	NULL
A1	NULL
expression	NULL
and	NULL
mitochondrial	NULL
homeostasis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

123	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

10	NULL
.	NULL

11	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

Biol	NULL
.	NULL

20:8855-8865.	NULL
.	NULL

Wang	NULL
,	NULL
C.Y	NULL
.	NULL

,	NULL
MW	NULL
.	NULL

Mayo	NULL
,	NULL
R.G	NULL
.	NULL

Kommeluk	NULL
,	NULL
D.V	NULL
.	NULL

Goeddel	NULL
,	NULL
and	NULL
A.S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1998	NULL
.	NULL

NF-KB	NULL
antiapoptosis	NULL
:	NULL
induction	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
and	NULL
c-IAP1	NULL
and	NULL
c-IAP2	NULL
to	NULL
suppress	NULL
caspase-8	NULL
activation	NULL
.	NULL

Science	NULL
.	NULL

281:1680-1683.	NULL
.	NULL

Bellacosa	NULL
,	NULL
A.	NULL
,	NULL
J.R.	NULL
Testa	NULL
,	NULL
S.P	NULL
.	NULL

Staal	NULL
,	NULL
and	NULL
P.N	NULL
.	NULL

Tsichlis	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
retroviral	NULL
oncogene	NULL
,	NULL
akt	NULL
,	NULL
encoding	NULL
a	NULL
serine-threonine	NULL
kinase	NULL
containing	NULL
an	NULL
SH2-like	NULL
region	NULL
.	NULL

Science	NULL
.	NULL

254:274-277.	NULL
.	NULL

Cryns	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
J.	NULL
Yuan	NULL
.	NULL

1998	NULL
.	NULL

Proteases	NULL
to	NULL
die	NULL
for	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

12:1551-1570.	NULL
.	NULL

Kluck	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
E.	NULL
Bossy-Wetzel	NULL
,	NULL
D.R	NULL
.	NULL

Green	NULL
,	NULL
and	NULL
D.D	NULL
.	NULL

New	NULL
meyer	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
from	NULL
mitochon-dria	NULL
:	NULL
a	NULL
primary	NULL
site	NULL
for	NULL
Bcl-2	NULL
regulation	NULL
of	NULL
apoptosis	NULL
.	NULL

Science	NULL
.	NULL

275:1132-1136.	NULL
.	NULL

Helgason	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
J.E	NULL
.	NULL

Damen	NULL
,	NULL
P.	NULL
Rosten	NULL
,	NULL
R.	NULL
Grewal	NULL
,	NULL
P.	NULL
So	NULL
rensen	NULL
,	NULL
S.M	NULL
.	NULL

Chappel	NULL
,	NULL
A.	NULL
Borowski	NULL
,	NULL
F.	NULL
Jirik	NULL
,	NULL
G.	NULL
Krystal	NULL
,	NULL
and	NULL
RK	NULL
.	NULL

Humphries	NULL
.	NULL

1998	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
SHIP	NULL
leads	NULL
to	NULL
hemopoietic	NULL
perturbations	NULL
,	NULL
lung	NULL
pathology	NULL
,	NULL
and	NULL
a	NULL
shortened	NULL
life	NULL
span	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

12:1610-1620	NULL
.	NULL

Di	NULL
Cristofano	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Kotsi	NULL
,	NULL
Y.F	NULL
.	NULL

Peng	NULL
,	NULL
C.	NULL
Cordon-Cardo	NULL
,	NULL
K.B	NULL
.	NULL

Elkon	NULL
,	NULL
and	NULL
P.P	NULL
.	NULL

Pandolfi	NULL
.	NULL

1999	NULL
.	NULL

Impaired	NULL
Fas	NULL
response	NULL
and	NULL
autoimmunity	NULL
in	NULL
mice	NULL
.	NULL

Science	NULL
.	NULL

285:2122-2125.	NULL
.	NULL

Aman	NULL
,	NULL
M.J.	NULL
,	NULL
TD	NULL
.	NULL

Lamkin	NULL
,	NULL
H.	NULL
Okada	NULL
,	NULL
T.	NULL
Kurosaki	NULL
,	NULL
and	NULL
K.S	NULL
.	NULL

Ravichandran	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
inositol	NULL
phosphatase	NULL
SHIP	NULL
inhibits	NULL
Akt/PKB	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:33922-33928	NULL
.	NULL

Wu	NULL
,	NULL
X.	NULL
,	NULL
K.	NULL
Senechal	NULL
,	NULL
M.S	NULL
.	NULL

Neshat	NULL
,	NULL
Y.E	NULL
.	NULL

Whang	NULL
,	NULL
and	NULL
C.L	NULL
.	NULL

Sawyers	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
PTEN/MMAC1	NULL
tumor	NULL
suppressor	NULL
phosphatase	NULL
functions	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
phosphoinositide	NULL
3-kinase/Akt	NULL
pathway	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

95:15587-15591	NULL
.	NULL

Coffer	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
J.	NULL
Jin	NULL
,	NULL
and	NULL
J.R.	NULL
Woodgett	NULL
.	NULL

1998	NULL
.	NULL

Protein	NULL
kinase	NULL
B	NULL
(	NULL
c-Akt	NULL
)	NULL
:	NULL
a	NULL
multifunctional	NULL
mediator	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
activation	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

335:1-13	NULL
.	NULL

Datta	NULL
,	NULL
SR.	NULL
,	NULL
A.	NULL
Brunet	NULL
,	NULL
and	NULL
M.E	NULL
.	NULL

Greenberg	NULL
.	NULL

1999	NULL
.	NULL

Cellular	NULL
survival	NULL
:	NULL
a	NULL
play	NULL
in	NULL
three	NULL
Akts	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

13:2905-2927	NULL
.	NULL

Koh	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
W.	NULL
Liecberthal	NULL
,	NULL
S.	NULL
Heydrick	NULL
,	NULL
and	NULL
J.S	NULL
.	NULL

Levine	NULL
.	NULL

1998	NULL
.	NULL

Lysophosphatidic	NULL
acid	NULL
is	NULL
a	NULL
major	NULL
serum	NULL
noncytokine	NULL
survival	NULL
factor	NULL
for	NULL
murine	NULL
macrophages	NULL
which	NULL
acts	NULL
via	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase	NULL
signaling	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

102	NULL
;	NULL
716-727	NULL
.	NULL

Franke	NULL
,	NULL
T.F	NULL
.	NULL

,	NULL
D.R	NULL
.	NULL

Kaplan	NULL
,	NULL
and	NULL
L.C	NULL
.	NULL

Cantley	NULL
.	NULL

1997	NULL
.	NULL

PI3K	NULL
:	NULL
downstream	NULL
AKTion	NULL
blocks	NULL
apoptosis	NULL
.	NULL

Cell	NULL
.	NULL

88:435-437	NULL
.	NULL

Datta	NULL
,	NULL
SR.	NULL
,	NULL
H.	NULL
Dudek	NULL
,	NULL
X.	NULL
Tao	NULL
,	NULL
S.	NULL
Masters	NULL
,	NULL
H.	NULL
Fu	NULL
,	NULL
Y.	NULL
Gotoh	NULL
,	NULL
and	NULL
M.E	NULL
.	NULL

Greenberg	NULL
.	NULL

1997	NULL
.	NULL

Akt	NULL
phosphorylation	NULL
of	NULL
BAD	NULL
couples	NULL
survival	NULL
signals	NULL
to	NULL
the	NULL
cell-intrinsic	NULL
death	NULL
machinery	NULL
.	NULL

Cell	NULL
.	NULL

91:231-241	NULL
.	NULL

Cardone	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
N.	NULL
Roy	NULL
,	NULL
H.R	NULL
.	NULL

Stennicke	NULL
,	NULL
G.S	NULL
.	NULL

Salvesen	NULL
,	NULL
T.F	NULL
.	NULL

Franke	NULL
,	NULL
E.	NULL
Stanbridge	NULL
,	NULL
S.	NULL
Frisch	NULL
,	NULL
and	NULL
J.C.	NULL
Reed	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
death	NULL
protease	NULL
caspase-9	NULL
by	NULL
phosphoryla-tion	NULL
.	NULL

Science	NULL
.	NULL

282:1318-1321	NULL
.	NULL

Kennedy	NULL
,	NULL
S.G.	NULL
,	NULL
E.S	NULL
.	NULL

Kandel	NULL
,	NULL
TK	NULL
.	NULL

Cross	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1999	NULL
.	NULL

Akt/protein	NULL
kinase	NULL
B	NULL
inhibits	NULL
cell	NULL
death	NULL
by	NULL
preventing	NULL
the	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
from	NULL
mitochondria	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
:	NULL
5800-5810	NULL
.	NULL

Sizemore	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Leung	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Stark	NULL
.	NULL

1999	NULL
.	NULL

Activation	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
in	NULL
response	NULL
to	NULL
interleukin-1	NULL
leads	NULL
to	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
p65/	NULL
RelA	NULL
subunit	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19:4798-4805	NULL
.	NULL

Beraud	NULL
,	NULL
C.	NULL
,	NULL
W.J	NULL
.	NULL

Henzel	NULL
,	NULL
and	NULL
P.A	NULL
.	NULL

Bacuerle	NULL
.	NULL

1999	NULL
.	NULL

Involvement	NULL
of	NULL
regulatory	NULL
and	NULL
catalytic	NULL
subunits	NULL
of	NULL
phosphoinositide	NULL
3-kinase	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

96	NULL
:	NULL
429-434	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Kane	NULL
,	NULL
L.P.	NULL
,	NULL
V.S	NULL
.	NULL

Shapiro	NULL
,	NULL
D.	NULL
Stokoe	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1999	NULL
.	NULL

Induction	NULL
of	NULL
NF-KB	NULL
by	NULL
the	NULL
Akt/PKB	NULL
kinase	NULL
.	NULL

Cur	NULL
.	NULL

Biol	NULL
.	NULL

9:601-604	NULL
.	NULL

Liu	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Sidiropoulos	NULL
,	NULL
G.	NULL
Song	NULL
,	NULL
LJ	NULL
.	NULL

Pagliari	NULL
,	NULL
M.J.	NULL
Birrer	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
J.	NULL
Anrather	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Pope	NULL
.	NULL

2000	NULL
.	NULL

TNF-	NULL
Â«	NULL
@	NULL
gene	NULL
expression	NULL
in	NULL
macrophages	NULL
:	NULL
regulation	NULL
by	NULL
NF-KB	NULL
is	NULL
independent	NULL
of	NULL
c-Jun	NULL
or	NULL
C/EBPB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:4277-4285	NULL
.	NULL

Moulding	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
R.V	NULL
.	NULL

Giles	NULL
,	NULL
D.G	NULL
.	NULL

Spiller	NULL
,	NULL
MR.	NULL
White	NULL
,	NULL
D.M	NULL
.	NULL

Tidd	NULL
,	NULL
and	NULL
S.W	NULL
.	NULL

Edwards	NULL
.	NULL

2000	NULL
.	NULL

Apoptosis	NULL
is	NULL
rapidly	NULL
triggered	NULL
by	NULL
antisense	NULL
depletion	NULL
of	NULL
Mcl-1	NULL
in	NULL
differentiating	NULL
U937	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

96:1756-1763	NULL
.	NULL

Perlman	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Sata	NULL
,	NULL
A	NULL
.	NULL

Le	NULL
Roux	NULL
,	NULL
T.	NULL
Sedlak	NULL
,	NULL
D.	NULL
Branellec	NULL
,	NULL
and	NULL
K.	NULL
Walsh	NULL
.	NULL

1998	NULL
.	NULL

Bax-mediated	NULL
cell	NULL
death	NULL
by	NULL
the	NULL
Gax	NULL
ho-meoprotein	NULL
requires	NULL
mitogen-activation	NULL
but	NULL
is	NULL
independent	NULL
of	NULL
cell	NULL
cycle	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:3576-3586	NULL
.	NULL

Perlman	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Georganas	NULL
,	NULL
LJ	NULL
.	NULL

Pagliari	NULL
,	NULL
A.E	NULL
.	NULL

Koch	NULL
,	NULL
K.	NULL
Haines	NULL
III	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Pope	NULL
.	NULL

2000	NULL
.	NULL

Bcl-2	NULL
expression	NULL
in	NULL
syn-ovial	NULL
fibroblasts	NULL
is	NULL
essential	NULL
for	NULL
maintaining	NULL
mitochondrial	NULL
homeostasis	NULL
and	NULL
cell	NULL
viability	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:5227-5235	NULL
.	NULL

Ando	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibata	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
L.	NULL
Kurihara	NULL
,	NULL
K.	NULL
Hayashi	NULL
,	NULL
M.	NULL
Hayashi	NULL
,	NULL
I.	NULL
Saito	NULL
,	NULL
H.	NULL
Kawabe	NULL
,	NULL
M.	NULL
Tsujioka	NULL
,	NULL
and	NULL
T.	NULL
Saruta	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
possible	NULL
role	NULL
of	NULL
apoptosis-suppressing	NULL
genes	NULL
,	NULL
bel-2	NULL
and	NULL
mcl-1/EAT	NULL
in	NULL
human	NULL
adrenal	NULL
tumors	NULL
.	NULL

Endocr	NULL
.	NULL

Res	NULL
.	NULL

24	NULL
:	NULL
955-960	NULL
.	NULL

Gerber	NULL
,	NULL
H.-P.	NULL
,	NULL
V.	NULL
Dixit	NULL
,	NULL
and	NULL
N.	NULL
Ferrara	NULL
.	NULL

1998	NULL
.	NULL

Vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
antiapoptotic	NULL
proteins	NULL
Bcl-2	NULL
and	NULL
Al	NULL
in	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:13313-13316	NULL
.	NULL

Vander	NULL
Heiden	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
N.S	NULL
.	NULL

Chandel	NULL
,	NULL
EK	NULL
.	NULL

Williamson	NULL
,	NULL
P.T	NULL
.	NULL

Schumacker	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Thompson	NULL
.	NULL

1997	NULL
.	NULL

Bcl-x	NULL
,	NULL
regulates	NULL
the	NULL
membrane	NULL
potential	NULL
and	NULL
volume	NULL
homeostasis	NULL
of	NULL
mitochondria	NULL
.	NULL

Cell	NULL
.	NULL

91:627-637	NULL
.	NULL

Biggs	NULL
,	NULL
W.H	NULL
.	NULL

III	NULL
,	NULL
J.	NULL
Meisenhelder	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
W.K	NULL
.	NULL

Cavenee	NULL
,	NULL
and	NULL
K.C	NULL
.	NULL

Arden	NULL
.	NULL

1999	NULL
.	NULL

Protein	NULL
kinase	NULL
B/Akt-mediated	NULL
phosphorylation	NULL
promotes	NULL
nuclear	NULL
exclusion	NULL
of	NULL
the	NULL
winged	NULL
helix	NULL
transcription	NULL
factor	NULL
FKHR1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

96	NULL
:	NULL
7421-7426	NULL
.	NULL

Romashkova	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
S.S.	NULL
Makarov	NULL
.	NULL

1999	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
target	NULL
of	NULL
AKT	NULL
in	NULL
anti-apoptotic	NULL
PDGF	NULL
signalling	NULL
.	NULL

Nature	NULL
.	NULL

401	NULL
:	NULL
86-90	NULL
.	NULL

Ozes	NULL
,	NULL
O.N	NULL
.	NULL

,	NULL
L.D	NULL
.	NULL

Mayo	NULL
,	NULL
J.A	NULL
.	NULL

Gustin	NULL
,	NULL
S.R	NULL
.	NULL

Pfeffer	NULL
,	NULL
LM	NULL
.	NULL

Pfeffer	NULL
,	NULL
and	NULL
D.B	NULL
.	NULL

Donner	NULL
.	NULL

1999	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor	NULL
requires	NULL
the	NULL
Akt	NULL
serine-threonine	NULL
kinase	NULL
.	NULL

Nature	NULL
.	NULL

401:82-85	NULL
.	NULL

Hu	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
H.	NULL
Johnson	NULL
,	NULL
and	NULL
H.B	NULL
.	NULL

Shu	NULL
.	NULL

1999	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-related	NULL
apoptosis-inducing	NULL
ligand	NULL
receptors	NULL
signal	NULL
NF-KB	NULL
and	NULL
JNK	NULL
activation	NULL
and	NULL
apoptosis	NULL
through	NULL
distinct	NULL
path-ways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:30603-30610	NULL
.	NULL

Madrid	NULL
,	NULL
LV	NULL
.	NULL

,	NULL
C.Y	NULL
.	NULL

Wang	NULL
,	NULL
D.C.	NULL
Guttridge	NULL
,	NULL
A.J	NULL
.	NULL

Schottelius	NULL
,	NULL
A.S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.W	NULL
.	NULL

Mayo	NULL
.	NULL

2000	NULL
.	NULL

Akt	NULL
suppresses	NULL
apoptosis	NULL
by	NULL
stimulating	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
RelA/p65	NULL
subunit	NULL
of	NULL
NF-KB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20:1626-1638	NULL
.	NULL

Moreb	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
and	NULL
M.	NULL
Schweder	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
A1	NULL
,	NULL
a	NULL
Bcl-2-related	NULL
gene	NULL
,	NULL
is	NULL
induced	NULL
in	NULL
leukemic	NULL
cells	NULL
by	NULL
cytokines	NULL
as	NULL
well	NULL
as	NULL
differentiating	NULL
factors	NULL
.	NULL

Leukemia	NULL
.	NULL

11:998-1004	NULL
.	NULL

Lin	NULL
,	NULL
E.Y	NULL
.	NULL

,	NULL
A.	NULL
Orlofsky	NULL
,	NULL
H.-G.	NULL
Wang	NULL
,	NULL
J.C.	NULL
Reed	NULL
,	NULL
and	NULL
M.B	NULL
.	NULL

Prystowsky	NULL
.	NULL

1996	NULL
.	NULL

A1	NULL
,	NULL
a	NULL
Bcl-2	NULL
family	NULL
member	NULL
,	NULL
prolongs	NULL
cell	NULL
survival	NULL
and	NULL
permits	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Blood	NULL
.	NULL

87:983-992	NULL
.	NULL

Kelley	NULL
,	NULL
T.W	NULL
.	NULL

,	NULL
M.M	NULL
.	NULL

Graham	NULL
,	NULL
A.I	NULL
.	NULL

Doseff	NULL
,	NULL
R.W	NULL
.	NULL

Pomerantz	NULL
,	NULL
S.M	NULL
.	NULL

Lau	NULL
,	NULL
M.C	NULL
.	NULL

Ostrowski	NULL
,	NULL
T.F	NULL
.	NULL

Franke	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Marsh	NULL
.	NULL

1999	NULL
.	NULL

Macrophage	NULL
colony-stimulating	NULL
factor	NULL
promotes	NULL
cell	NULL
survival	NULL
through	NULL
Akt/protein	NULL
kinase	NULL
B.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
:	NULL
124	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

26393-26398	NULL
.	NULL

Hmama	NULL
,	NULL
Z.	NULL
,	NULL
D.	NULL
Nandan	NULL
,	NULL
L.	NULL
Sly	NULL
,	NULL
K.L	NULL
.	NULL

Knutson	NULL
,	NULL
P.	NULL
Herrera-Velit	NULL
,	NULL
and	NULL
N.E	NULL
.	NULL

Reiner	NULL
.	NULL

1999	NULL
.	NULL

1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
(	NULL
3	NULL
)	NULL
-induced	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
vitamin	NULL
D	NULL
receptor-phosphatidylinositol	NULL
3-kinase	NULL
signaling	NULL
complex	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

190:1583-1594	NULL
.	NULL

Hamilton	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
J.	NULL
Chan	NULL
,	NULL
R.J.	NULL
Byme	NULL
,	NULL
R.J.	NULL
Bischof	NULL
,	NULL
A.	NULL
Ja-worowski	NULL
,	NULL
and	NULL
V.	NULL
Kanagasundaram	NULL
.	NULL

1998	NULL
.	NULL

MRL/lpr	NULL
and	NULL
MRL*'*	NULL
macrophage	NULL
DNA	NULL
synthesis	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
colony-stimulating	NULL
factor-1	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161	NULL
:	NULL
6802-6811	NULL
.	NULL

Smith	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
A.E	NULL
.	NULL

Schaffner	NULL
,	NULL
J.K.	NULL
Hofmeister	NULL
,	NULL
M.	NULL
Hartman	NULL
,	NULL
G.	NULL
Wei	NULL
,	NULL
D.	NULL
Forsthoefel	NULL
,	NULL
D.A	NULL
.	NULL

Hume	NULL
,	NULL
and	NULL
M.C	NULL
.	NULL

Ostrowski	NULL
.	NULL

2000.	NULL
ets-2	NULL
is	NULL
a	NULL
target	NULL
for	NULL
an	NULL
akt	NULL
(	NULL
protein	NULL
kinase	NULL
B	NULL
)	NULL
/Jun	NULL
N-terminal	NULL
kinase	NULL
signaling	NULL
pathway	NULL
in	NULL
macrophages	NULL
of	NULL
motheaten-viable	NULL
mutant	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20:8026-8034	NULL
.	NULL

Hausler	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Papoff	NULL
,	NULL
A.	NULL
Eramo	NULL
,	NULL
K.	NULL
Reif	NULL
,	NULL
D.A	NULL
.	NULL

Cantrell	NULL
,	NULL
and	NULL
G.	NULL
Ruberti	NULL
.	NULL

1998	NULL
.	NULL

Protection	NULL
of	NULL
CD95-mediated	NULL
apoptosis	NULL
by	NULL
activation	NULL
of	NULL
phosphatidylinositide	NULL
3-kinase	NULL
and	NULL
protein	NULL
kinase	NULL
B.	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:57-69	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
,	NULL
X.-M.	NULL
Li	NULL
,	NULL
J.	NULL
Meinkoth	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Pittman	NULL
.	NULL

2000	NULL
.	NULL

Akt	NULL
regulates	NULL
cell	NULL
survival	NULL
and	NULL
apoptosis	NULL
at	NULL
a	NULL
postmitochondrial	NULL
level	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

151:483-494	NULL
.	NULL

Susin	NULL
,	NULL
S.A.	NULL
,	NULL
HK	NULL
.	NULL

Lorenzo	NULL
,	NULL
N.	NULL
Zamzami	NULL
,	NULL
I.	NULL
Marzo	NULL
,	NULL
C.	NULL
Bren-ner	NULL
,	NULL
N.	NULL
Larochette	NULL
,	NULL
M.C	NULL
.	NULL

Prevost	NULL
,	NULL
P.M.	NULL
Alzari	NULL
,	NULL
and	NULL
G.	NULL
Kroe-mer	NULL
.	NULL

1999	NULL
.	NULL

Mitochondrial	NULL
release	NULL
of	NULL
caspase-2	NULL
and	NULL
-9	NULL
during	NULL
the	NULL
apoptotic	NULL
process	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

189:381-394	NULL
.	NULL

Susin	NULL
,	NULL
S.A.	NULL
,	NULL
E.	NULL
Daugas	NULL
,	NULL
L.	NULL
Ravagnan	NULL
,	NULL
K.	NULL
Samejima	NULL
,	NULL
N.	NULL
Zamzami	NULL
,	NULL
M.	NULL
Loeffler	NULL
,	NULL
P.	NULL
Costantini	NULL
,	NULL
K.F	NULL
.	NULL

Fer	NULL
,	NULL
T.	NULL
Irino-poulou	NULL
,	NULL
M.C	NULL
.	NULL

Prevost	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2000	NULL
.	NULL

Two	NULL
distinct	NULL
pathways	NULL
leading	NULL
to	NULL
nuclear	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

192:571-580.	NULL
del	NULL
Peso	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Gonzalez-Garcia	NULL
,	NULL
C.	NULL
Page	NULL
,	NULL
R.	NULL
Herrera	NULL
,	NULL
and	NULL
G.	NULL
Nunez	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-3-induced	NULL
phosphorylation	NULL
of	NULL
BAD	NULL
through	NULL
the	NULL
protein	NULL
kinase	NULL
Akt	NULL
.	NULL

Science	NULL
.	NULL

278:687-689	NULL
.	NULL

Eves	NULL
,	NULL
EM	NULL
.	NULL

,	NULL
W.	NULL
Xiong	NULL
,	NULL
A.	NULL
Bellacosa	NULL
,	NULL
S.G.	NULL
Kennedy	NULL
,	NULL
P.N	NULL
.	NULL

Tsichlis	NULL
,	NULL
M.R	NULL
.	NULL

Rosner	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1998	NULL
.	NULL

Akt	NULL
,	NULL
a	NULL
target	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
,	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
a	NULL
differentiating	NULL
neuronal	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:2143-2152	NULL
.	NULL

Reddy	NULL
,	NULL
S.A.	NULL
,	NULL
J.H	NULL
.	NULL

Huang	NULL
,	NULL
and	NULL
W.S	NULL
.	NULL

Liao	NULL
.	NULL

2000	NULL
.	NULL

Phosphatidylinositol	NULL
3-kinase	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
TNF-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:1355-1363	NULL
.	NULL

Hayes	NULL
,	NULL
A.L	NULL
.	NULL

,	NULL
C.	NULL
Smith	NULL
,	NULL
B.M.J	NULL
.	NULL

Foxwell	NULL
,	NULL
and	NULL
F.M	NULL
.	NULL

Brennan	NULL
.	NULL

1999	NULL
.	NULL

CD-45-induced	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
production	NULL
in	NULL
monocytes	NULL
is	NULL
phosphatidylinositol-kinase	NULL
dependent	NULL
and	NULL
nuclear	NULL
factor-kB-independent	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:33455-33461	NULL
.	NULL

Jones	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
M.	NULL
Parsons	NULL
,	NULL
M.	NULL
Bonnard	NULL
,	NULL
V.S	NULL
.	NULL

Chan	NULL
,	NULL
W.C.	NULL
Yeh	NULL
,	NULL
J.R.	NULL
Woodgett	NULL
,	NULL
and	NULL
P.S	NULL
.	NULL

Ohashi	NULL
.	NULL

2000	NULL
.	NULL

Protein	NULL
kinase	NULL
B	NULL
regulates	NULL
T	NULL
lymphocyte	NULL
survival	NULL
,	NULL
nuclear	NULL
factor	NULL
KB	NULL
activation	NULL
,	NULL
and	NULL
Bcl-X	NULL
(	NULL
L	NULL
)	NULL
levels	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191:1721-1734	NULL
.	NULL

Wang	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
J.R.	NULL
Chao	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
M.L	NULL
.	NULL

Kuo	NULL
,	NULL
J.J	NULL
.	NULL

Yen	NULL
,	NULL
and	NULL
H.F.	NULL
Yang-Yen	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
antiapoptotic	NULL
gene	NULL
mel-1	NULL
is	NULL
up-regulated	NULL
by	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase/Akt	NULL
signaling	NULL
pathway	NULL
through	NULL
a	NULL
transcription	NULL
factor	NULL
complex	NULL
containing	NULL
CREB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19:6195-6206	NULL
.	NULL

Rinkenberger	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
S.	NULL
Homing	NULL
,	NULL
B.	NULL
Klocke	NULL
,	NULL
K.	NULL
Roth	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Korsmeyer	NULL
.	NULL

2000	NULL
.	NULL

Mcl-1	NULL
deficiency	NULL
results	NULL
in	NULL
peri-implanta-tion	NULL
embryonic	NULL
lethality	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

14:23-27	NULL
.	NULL

Krajewski	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Bodrug	NULL
,	NULL
M.	NULL
Krajewska	NULL
,	NULL
A.	NULL
Shabaik	NULL
,	NULL
R.	NULL
Gas-coyne	NULL
,	NULL
K.	NULL
Berean	NULL
,	NULL
and	NULL
J.C.	NULL
Reed	NULL
.	NULL

1995	NULL
.	NULL

Immunohistochem-ical	NULL
analysis	NULL
of	NULL
Mcl-1	NULL
protein	NULL
in	NULL
human	NULL
tissues	NULL
.	NULL

Differential	NULL
Constitutive	NULL
Akt-1	NULL
Activation	NULL
Is	NULL
Essential	NULL
for	NULL
Macrophage	NULL
Survival	NULL
53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56.	NULL
regulation	NULL
of	NULL
Mcl-1	NULL
and	NULL
Bcl-2	NULL
protein	NULL
production	NULL
suggests	NULL
a	NULL
unique	NULL
role	NULL
for	NULL
Mcl-1	NULL
in	NULL
control	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
vivo	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

146:1309-1319	NULL
.	NULL

Chao	NULL
,	NULL
J.R.	NULL
,	NULL
JJM	NULL
.	NULL

Wang	NULL
,	NULL
S.F	NULL
.	NULL

Lee	NULL
,	NULL
H.W	NULL
.	NULL

Peng	NULL
,	NULL
Y.H	NULL
.	NULL

Lin	NULL
,	NULL
C.H	NULL
.	NULL

Chou	NULL
,	NULL
J.C.	NULL
Li	NULL
,	NULL
HM	NULL
.	NULL

Huang	NULL
,	NULL
C.K	NULL
.	NULL

Chou	NULL
,	NULL
M.L	NULL
.	NULL

Kuo	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998.	NULL
is	NULL
an	NULL
immediate-early	NULL
gene	NULL
activated	NULL
by	NULL
the	NULL
granulocyte-macrophage	NULL
-	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
signaling	NULL
pathway	NULL
and	NULL
is	NULL
one	NULL
component	NULL
of	NULL
the	NULL
GM-CSF	NULL
viability	NULL
response	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:4883-4898	NULL
.	NULL

Zhou	NULL
,	NULL
P.	NULL
,	NULL
L.	NULL
Qian	NULL
,	NULL
K.M	NULL
.	NULL

Kozopas	NULL
,	NULL
and	NULL
R.W	NULL
.	NULL

Craig	NULL
.	NULL

1997	NULL
.	NULL

Mcl-1	NULL
,	NULL
a	NULL
Bcl-2	NULL
family	NULL
member	NULL
,	NULL
delays	NULL
the	NULL
death	NULL
of	NULL
hematopoietic	NULL
cells	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
apoptosis-inducing	NULL
conditions	NULL
.	NULL

Blood	NULL
.	NULL

89:630-643	NULL
.	NULL

Wang	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
G.P	NULL
.	NULL

Studzinski	NULL
.	NULL

1997	NULL
.	NULL

Antiapoptotic	NULL
action	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D3	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
mitochondrial	NULL
MCL-1	NULL
and	NULL
RAF-1	NULL
proteins	NULL
and	NULL
reduced	NULL
release	NULL
of	NULL
cytochrome	NULL
c.	NULL
Exp	NULL
.	NULL

Cell	NULL
.	NULL

Res	NULL
.	NULL

235:210-217	NULL
.	NULL

Zhou	NULL
,	NULL
P.	NULL
,	NULL
L.	NULL
Qian	NULL
,	NULL
C.K	NULL
.	NULL

Bieszczad	NULL
,	NULL
R.	NULL
Noelle	NULL
,	NULL
M.	NULL
Binder	NULL
,	NULL
N.B	NULL
.	NULL

Levy	NULL
,	NULL
and	NULL
R.W	NULL
.	NULL

Craig	NULL
.	NULL

1998	NULL
.	NULL

Mcl-1	NULL
in	NULL
transgenic	NULL
mice	NULL
125	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60.	NULL
promotes	NULL
survival	NULL
in	NULL
a	NULL
spectrum	NULL
of	NULL
hematopoietic	NULL
cell	NULL
types	NULL
and	NULL
immortalization	NULL
in	NULL
the	NULL
myeloid	NULL
lineage	NULL
.	NULL

Blood	NULL
.	NULL

92:3226-3239	NULL
.	NULL

Sedlak	NULL
,	NULL
T.W	NULL
.	NULL

,	NULL
Z.N	NULL
.	NULL

Oltvai	NULL
,	NULL
E.	NULL
Yang	NULL
,	NULL
K.	NULL
Wang	NULL
,	NULL
LH	NULL
.	NULL

Boise	NULL
,	NULL
C.B	NULL
.	NULL

Thompson	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Korsmeyer	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
Bcl-2	NULL
family	NULL
members	NULL
demonstrate	NULL
selective	NULL
dimerizations	NULL
with	NULL
Bax	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

92:7834-7838	NULL
.	NULL

Pastorino	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
S.T	NULL
.	NULL

Chen	NULL
,	NULL
M.	NULL
Tafani	NULL
,	NULL
J.	NULL
W.	NULL
Snyder	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Farber	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
overexpression	NULL
of	NULL
Bax	NULL
produces	NULL
cell	NULL
death	NULL
upon	NULL
induction	NULL
of	NULL
the	NULL
mitochondrial	NULL
permeability	NULL
transition	NULL
.	NULL

_J	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:7770-7775	NULL
.	NULL

Pastorino	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
M.	NULL
Tafani	NULL
,	NULL
R.J.	NULL
Rothman	NULL
,	NULL
A.	NULL
Marcinkevi-ciute	NULL
,	NULL
J.B.	NULL
Hoek	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Farber	NULL
.	NULL

1999	NULL
.	NULL

Functional	NULL
consequences	NULL
of	NULL
the	NULL
sustained	NULL
or	NULL
transient	NULL
activation	NULL
by	NULL
Bax	NULL
of	NULL
the	NULL
mitochondrial	NULL
permeability	NULL
transition	NULL
pore	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:31734-31739	NULL
.	NULL

Zhang	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Yu	NULL
,	NULL
BH	NULL
.	NULL

Park	NULL
,	NULL
K.W	NULL
.	NULL

Kinzler	NULL
,	NULL
and	NULL
B.	NULL
Vogel-stein	NULL
.	NULL

2000	NULL
.	NULL

Role	NULL
of	NULL
BAX	NULL
in	NULL
the	NULL
apoptotic	NULL
response	NULL
to	NULL
anti-cancer	NULL
agents	NULL
.	NULL

Science	NULL
.	NULL

290:989-992	NULL
.	NULL

